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Nuclear organization has been implicated in regulating gene activity. Recently, 
large developmentally regulated regions of the genome that are dynamically associated 
with the nuclear lamina have been identified. However, little is known about how these 
lamina-associated domains (LADs) are directed to the nuclear lamina. We have 
generated genome-wide data that identifies lamina associated regions in desperate cell 
types, to study the organization of LADs. We utilize this data in combination with the 
development of the tagged chromosomal insert site system (TCIS) to discern the 
structural and functional relationships behind nuclear organization.  
The TCIS system is comprised of a recombination cassette, to allow site-specific 
Cre-mediated recombination, as well as a lacO array that can reversibly bind EGFP-LacI 
for visualization of the locus. TCIS is then integrated in a single copy in a single location 
in fibroblast genome. Thus, TCIS enables integration of a single copy of any DNA 
fragment into the genome by directed recombination into the TCIS site and its 
visualization.  Because any genomic element of interest can be specifically recombined 
into TCIS, this system is ideal for assaying association with a nuclear compartment of 
interest. This system makes it possible to study the mechanistic and functional 
consequences of genome organization at a single locus in a native state.  
In this work we utilize TCIS to investigate the structural/functional relationships of 
the periphery as a nuclear sub-compartment. We have generated genome-wide data 
produced by DNA Adenine Methyltransferase Identification (Dam-ID) to identify small 
sequences from the borders of fibroblast-specific variable LADs that are sufficient to 
target these ectopic sites to the nuclear periphery. We identified YY1 (Ying-Yang1), 
CTCF, BTB-POZ domain protein binding sites (amongst others) as being enriched in 
relocating sequences. Knockdown of YY1 or lamin A/C, but not lamin A, led to a loss of 
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lamina association. In addition, targeted recruitment of YY1 proteins facilitated ectopic 
LAD formation dependent on histone H3 lysine 27 trimethylation and histone H3 lysine 
di- and tri-methylation. Our results also reveal that endogenous loci appear to be 
dependent on lamin A/C, YY1, H3K27me3, and H3K9me2/3 for maintenance of lamina-
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1.1: Gene regulation and chromatin organization 
Developmentally regulated genes become activated or repressed by a variety of 
mechanisms involving both local and global changes. Local changes include direct 
interactions of trans factors (i.e. cell/developmentally specific transcription factors) or cis 
factors in the DNA (i.e. promotors and regulatory elements). In eukaryotic cells, DNA is 
organized into nucleosomes containing 146 bases of DNA wrapped 1.65 times around a 
histone protein octamer consisting of two H2A and B heterodimers and a histone H3/H4 
tetramer (Luger, Mäder, Richmond, Sargent, & Richmond, 1997). These nucleosomes 
are then packaged into chromatin (DNA plus histones with associated proteins and 
complexes) which serves as the substrate for virtually all nuclear events (transcription, 
replication, recombination, and repair). Modulation of transcription (and other DNA-
based activities) is influenced by changes in the post-translational modifications of 
histone tails, DNA methylation patterns and/or nucleosome positioning.  In particular, 
such modifications to chromatin impact the ability of specific transcription factors to 
interact with their cognate binding site(s) and conversely, binding of a given transcription 
factor to its binding site can alter local chromatin structure, thus tightly linking 
transcription of a gene with its chromatin state. There are two broad ‘types’ of chromatin: 
heterochromatin which is more densely packed and thus repressive to gene activity and 
euchromatin which is more open and permissive to gene expression (Figure 1.1). 
Because such modifications to the chromatin influence gene expression and are 
heritable through the cell-cycle, this type of control is called ‘epigenetic’ regulation. 
Intriguingly, more recent evidence strongly suggests that there is another more global 
level of epigenetic regulation, involving changes in nuclear localization, associations with 
repressive compartments, such as the nuclear periphery or pericentromeric 
heterochromatin, and large-scale changes in DNA structure, such as the formation of 







Figure 1.1: Chromatin organization. Chromatin is comprised of DNA, histones and 
associated proteins. The basic unit of chromatin is the nucleosome. The nucleosome is 
a histone octamer (Histone H3/H4 tetramer, and two H2A and B heterodimers) wrapped 
1.65 times by 147bp of DNA.  Post translational modifications (PTMs) on histone tails, 
decorate the outside of the nucleosome. Common histone modifications include 
methylation, acetylation, ubiquitination, sumoylation and phosphorylation. In general 
there are two forms of chromatin, a more open form in which transcription factors and 
proteins can interact with DNA, (euchromatin) and a more closed structure where the 
DNA is less accessible (heterochromatin).  Euchromatin is generally permissive to 
transcription and is commonly decorated with acetylation of H3 and H4. In contrast, 
heterochromatin is generally repressed and contains, H3K27me3 and H3K9me2/3. This 
basic level of chromatin organization underlies a more complex interplay of chromatin 
with in subdomains in the nucleus which appear to organize DNA and regulatory factors 





dimensional organization changes during development or upon environmental cues and, 
more importantly, how these changes may impact genome/epigenome regulation. 
 
1.2: The nuclear periphery and chromosome organization 
The nuclear periphery in metazoan cells is composed of a unique set of inner 
nuclear membrane (INM) proteins and the nuclear lamina (Verstraeten, Broers, 
Ramaekers, & van Steensel, 2007). Mammalian INM proteins include, but are not limited 
to, lamin B receptor (LBR), lamina associated peptide2 (Lap2) and Emerin (Wilson & 
Berk, 2010). These and other INM proteins interact with the nuclear lamina, which is 
made up of a filamentous meshwork of proteins: lamins A/C and B (Gerace & Burke, 
1988; Moir, Montag-Lowy, & Goldman, 1994; Stuurman, Heins, & Aebi, 1998). LBR, 
Emerin, and Lap2, for example, have been shown to interact with transcriptional 
repressors. Specifically, LBR has been shown to interact with heterochromatin protein 
1α (HP1α) and nucleosomes through the core histones H3 and H4 and the LEM (Lap2β, 
Emerin, MAN1) domain containing proteins, Emerin and Lap2β, interact with Barrier to 
Auto-integration Factor (BAF), germ-cell-less (GCL), retinoblastoma protein (Rb) and 
HDAC3 (Holaska & Wilson, 2007; Kourmouli et al., 2000; Somech et al., 2005; Ye, 
Callebaut, Pezhman, Courvalin, & Worman, 1997; Ye & Worman, 1996). These studies 
suggest a strong role for the INM in genome regulation. 
A growing body of evidence suggests that the proteome at the INM is quite 
complex, containing over 100 different and differentially expressed transmembrane 
proteins, many of which are developmentally regulated or variably expressed across cell 
types (Florens, Korfali, & Schirmer, 2008; Korfali et al., 2010; Malik et al., 2010; 
Schirmer & Foisner, 2007; Wilkie & Schirmer, 2008; Wilson & Berk, 2010; Wilson & 
Foisner, 2010). High throughput proteomics approaches that assay for all nuclear 




that vary depending upon cell type. These proteins include both well-known and novel 
INM proteins (Korfali et al., 2012). It has been demonstrated that these tissue and cell 
type specific NETs contribute to cell type specific peripheral localization of whole 
chromosomes and, potentially, to cell type specific gene regulation (Zuleger et al., 2013).  
An example of such differentially expressed proteins playing a role in genome 
regulation and organization is LBR. Even before these more recent studies using 
advanced proteomics tools, the level of LBR was known to affect genome organization 
and developmental progression in certain tissues (Gaines et al., 2008; A L Olins, 
Herrmann, Lichter, & Olins, 2000; A. Olins & Olins, 2004; Solovei et al., 2013; Zwerger, 
Herrmann, Gaines, Olins, & Olins, 2008). LBR has multifunctional roles at the INM, 
including the promotion of membrane growth and regulation of genome organization by 
its ability to bind to epigenetic factors (e. g histones and HP1) and B type lamins (Gaines 
et al., 2008; Ada L Olins, Rhodes, Welch, Zwerger, & Olins; Zwerger et al., 2008). The 
expression levels of LBR are correlated with the degree of segmentation or hyper-
lobulation of granulocyte nuclei, proper heterochromatin organization and neutrophil 
development during granulopoeisis, as promyelocytes (or earlier precursors) differentiate 
into granulocytes. Furthermore, both LBR and lamins A and C have been implicated in 
recruiting or scaffolding heterochromatin at the nuclear periphery (Gaines et al., 2008; A 
L Olins et al., 2000; A. Olins & Olins, 2004; Solovei et al., 2013; Zwerger et al., 2008). 
Additionally, when cells are devoid of both LBR and lamin A/C they exhibit an inverted 
chromatin configuration similar to that seen in rod cells of nocturnal animals that 
naturally lack LBR and lamin A/C expression (Solovei et al., 2009, 2013). This inverted 
configuration displays heterochromatin occupancy in the nuclear interior while 
euchromatin has a more peripheral association. This organization is critical for 
diminishing light scattering and hence allowing vision under low light conditions (Solovei 




expression of lamin C in rod cells did not, suggesting the requirement of mediator(s) for 
anchoring chromatin to the nuclear periphery (Solovei et al., 2013). It is currently unclear 
exactly which of the A-type lamins are responsible for maintaining normal scaffolding of 
heterochromatin to the lamina. 
 
1.3: The chromatin compartment at the nuclear periphery-Lamina Associated 
Domains (LADs) 
Early cytological studies using electron-microscopy clearly show heterochromatin 
enriched at the nuclear periphery, suggesting that this region of the nucleus acts as a 
compartment that contains inactive regions of DNA. A natural hypothesis to emerge from 
these observations is that chromatin in this regions will harbor epigenetic characteristics 
of heterochromatin. In recent years, the DNA Adenine Methyltransferase Identification 
(DamID) technique has been used to map genome-wide chromatin contacts at the 
nuclear periphery to identify lamina associated domains (LADs) of DNA (Vogel, Peric-
Hupkes, & van Steensel, 2007 and see Chapter 2 for a more detailed discription of the 
technique). Initial reports characterized LADs as large (0. 1-10Mb) silent domains with 
low gene density or ‘gene deserts’ (Guelen et al., 2008). More recent studies, and the 
work herein, have focused instead on LADs that do contain genes. Studying this subset 
of LADs enables the exploration of the function such organization may play in gene 
regulation (Reddy, Zullo, Bertolino, & Singh, 2008; Zullo et al., 2012). In particular, 
developmentally regulated genes appear to be enriched in these domains, leading to the 
hypothesis that LADs serve as ‘facultative’ heterochromatin domains during 
development (Meuleman et al., 2013; Peric-Hupkes et al., 2010). Additionally, while 
LADs are mostly composed of heterochromatin (see below), it is important to note that 
there are several examples of lamina-proximal genes that are actively transcribed 




These genes may interact with nuclear pore complexes, which have been shown to 
reside in a euchromatic environment, perhaps to both facilitate transcriptional activation 
and transport mRNA into the cytoplasm (Brickner et al., 2012). However, the large 
domains of chromatin that come in molecular contact with the nuclear lamina are 
repressed and it is these inactive, but gene-containing, LADs that are an active area of 
research for our group—specifically to uncover their role in chromosome architecture 
and gene regulation.  
DamID studies in our lab and others’ have implicated LADs in both epigenetic 
modulation and control of gene expression. These studies rely on intersecting DamID 
data with genome-wide chromatin immunoprecipitation (ChIP) analyses used to detect 
epigenetic modifications and transcriptional regulators across the genome (and with high 
resolution). Specifically, it has been noted that LAD borders, but not the interior of these 
domains, are enriched in the facultative heterochromatin histone H3 lysine 27 
trimethylation (H3K27me3) (Guelen et al., 2008; Zullo et al., 2012, Shah et al., 2013). In 
this original study, a modest but not impressive correlation with Histone lysine 9 tri-
methylation (H3K9me3) was noted, and  similar ChIP experiments for the histone H3 
lysine 9 di- or tri-methylation (H3K9me2/3) modification shows a domain profile similar to 
LAD in size, distribution and position (Bo Wen, Wu, Shinkai, Irizarry, & Feinberg, 2009). 
When these large organized chromatin K9 modifications (LOCKs) were compared to 
available LAD data, an approximately 80% overlap was noted. However, these assays 
were done in disparate cell types, so the extent of LAD/LOCK is currently unknown. 
Nonetheless, it appears that these two heterochromatin marks, H3K27me3 and 
H3K9me2/3, are correlated with LADs. We note, however, that H3K27me3, unlike 
H3K9me2/3, is found mostly outside of lamina proximal domains, with a higher than 
expected enrichment at LAD borders (Guelen et al., 2008 and see Chapter 2). Our work 




state, i.e. if LAD association is dependent upon chromatin state or vice versa (or both). 
Several recent studies have implicated chromatin status in directing LAD organization. A 
modified live-cell DamID protocol, using a highly clonal cancer cell line, showed that 
reduction in G9a, the methyltransferase that deposits H3K9me3 modifications, led to a 
‘loosening’ of LAD structure near the nuclear periphery (Kind et al., 2013). Additionally, a 
series of experiments in C. elegans pointed to the role for H3K9me2 in targeting to the 
periphery and subsequent accumulation of H3K9me3 in these domains after becoming 
lamina proximal (Towbin et al., 2012). However, in embryonic stem cells (ESCs), 
profound differences in these domains were observed with LOCKs being largely absent 
and LADs displaying robust configuration (Peric-Hupkes et al., 2010; Bo Wen et al., 
2009). Interestingly, the genomes of ESCs demonstrate a unique overall 3D organization 
(de Wit et al., 2013). Given these data we propose that epigenetic state and LAD 
organization are inter-related, and we describe in chapter two how these modifications 
are required for formation and/or maintenance of lamina associated domains.   
Given the studies implicating chromatin state in directing compartmentalization, it 
is important to note that forced localization of genes to the inner nuclear membrane 
leads to their repression, indicating that this compartment may also contribute to 
epigenetic changes (Finlan et al., 2008; Kumaran & Spector, 2008; Reddy et al., 2008). 
These functional experiments are consistent with numerous genome-wide and 
cytological studies examining lamina proximal chromatin (Kosak et al., 2002; Meister, 
Towbin, Pike, Ponti, & Gasser, 2010; Peric-Hupkes et al., 2010; Williams et al., 2006; 
Yao et al., 2011; Zullo et al., 2012). Taken together these data strongly suggest a role 
for the nuclear periphery as a compartment that functions in the dynamic establishment 
and/or maintenance of gene repression. A rapidly growing focus of research is on the 
developmentally and cell type specific dynamic interaction of the genome and 




1.4 Additional features of LADs and LAD borders 
Additional analyses of genomic features in the context of lamina associated 
domains have revealed a few characteristics that further suggest functionality and 
dynamics of the chromatin present at the nuclear periphery. Consistent with gene-poor 
and repressed chromatin, LINE elements and A/T sequences are enriched in LADs, as 
are promoters in adjacent domains that drive transcription away from LAD border 
regions, perhaps contributing to the delineation of the borders (Meuleman et al., 2013). It 
is interesting to note that H3K9me2/3 domains that correlate highly with LADs have 
“islands of euchromatin” within a larger LOCK domain, as evidenced by low H3K9me2/3 
signal, and these islands overlap with transcription start sites (B Wen et al., 2012). We 
note these same breaks in LAD organization, suggesting a link between H3K9me2/3, 
transcription and LAD organization over these regions. The potential functional role of 
these regions is unknown, but they may be indicative of regulatory regions important to 
LAD dynamics and/or may have a role in scaffolding.  
In addition to the H3K27me3 modifications noted above, the borders of LADs 
appear to be enriched in binding sites for the chromatin organizer CTCF (CCCTC-
binding factor) (Dixon et al., 2012; Guelen et al., 2008; Handoko et al., 2011; Nora et al., 
2012; Zullo et al., 2012). CTCF is a highly conserved zinc finger DNA binding protein 
that acts as an insulator and has also been shown to interact with DNA in large and 
varied protein complexes to facilitate long range inter- and intra- chromosomal 
interactions (Van Bortle & Corces, 2013). CTCF is also involved in higher order 
organization of the genome into topological domains, also known as Topologically 
Associating Domains or TADs (Dixon et al., 2012; Li et al., 2013; Nora et al., 2012; 
Phillips-Cremins et al., 2013; Sexton et al., 2012). TADs are large domains of the 
genome, detected by chromosome conformation capture derivative methods (5C or Hi-




with adjacent TADs (Dixon et al., 2012). Intriguingly, LADS and TADs share boundaries 
with a much higher than expected frequency than expected by chance, but many LADs 
cross topological domain boundaries and vice versa, suggesting that these structures 
are not identical. (Dixon et al., 2012; Nora et al., 2012; Phillips-Cremins et al., 2013). In 
addition, LADs are quite dynamic across cell types, while TADs are much less so, with 
sub-domains within TADs showing much greater changes between cell types.  
Interestingly, CTCF has been proposed to interact with Ying-Yang1 (YY1) to 
mediate sub-TAD cell type–specific organization, raising the possibility that CTCF and 
YY1 act together to target and delimit LAD boundaries (Phillips-Cremins et al., 2013). 
Numerous studies have implicated the interaction of these two proteins in both nuclear 
architecture and in gene regulation (Donohoe et al., 2007; Kim, 2008; Nikolaev et al., 
2009; Degner et al., 2011; Weth and Renkawitz, 2011; Medvedovic et al., 2013; Wei et 
al., 2013). YY1 itself is a general transcription factor that has been implicated in both 
activation and repression of specific genes (Deng et al., 2010). Intriguingly, YY1 has 
been speculated to mediate gene repression through recruitment of the polycomb 
repressive complex (PRC2), which introduces H3K27me3 through the activity of EZH2 
(Enhancer of Zeste 2), a component of PRC2 (Atchison, Ghias, Wilkinson, Bonini, & 
Atchison, 2003; Basu, Wilkinson, Colavita, Fennelly, & Atchison, 2014; Srinivasan & 
Atchison, 2004; Wilkinson, Pratt, & Atchison, 2010). In mammalian cells it is unclear how 
PRC2 is recruited to DNA. In drosophila, YY1 has been shown to interact with the EED 
component of YY1 (Atchison, Ghias, Wilkinson, Bonini, & Atchison, 2003; Caretti, Di 
Padova, Micales, Lyons, & Sartorelli, 2004; Meara & Simon, 2012; Satijn, Hamer, den 
Blaauwen, & Otte, 2001). As previously mentioned, the chromatin insulator protein 
CTCF has been shown to have its cell-type specific functions, for example in X-
chromosome inactivation, modulated by neighboring DNA binding factors, such as YY1 




& Corces, 2013; Zlatanova & Caiafa, 2009) To date, no direct role for H3K27me3, CTCF 
or YY1 in LAD organization has been elucidated.  
 
1.5: Three dimensional regulation of the immunoglobulin heavy chain locus 
 For proper coordination with lymphocyte differentiation, the somatic 
rearrangement of lymphocyte receptor loci must be lineage and developmental stage 
specific. However, the RAG (Recombination Activating Gene) recombinases, which 
enable the somatic rearrangement of the antigen receptors, are expressed in B and T 
cells and their progenitors, and other factors involved in V(D)J recombination are 
ubiquitous (e.g. factors involved in nonhomologous end joining). Specificity of this 
process is therefore guaranteed only through cell-type specific transcriptional and 
epigenetic environments, making the antigen receptor genes model loci for 
understanding how key developmentally regulated genes are controlled. Multiple 
developmentally regulated mechanisms appear to be responsible for relieving repression 
of the Igh loci as cells are specified to the B cell lineage. In non-B cells and progenitor 
cells the heavy-chain locus is found in a repressed state (H3K9 methylated, hypo-
acetylated) at the nuclear periphery. Early in B cell development, key transcriptional 
regulators such as E2A (E2a immunoglobulin enhance binding factors E12/E47, aka 
TCF3 or transcription factor 3) and EBF (early B cell factor) are upregulated (K L Medina 
& Singh, 2005). This coincides with the rearrangement and transcription of the DJ H 
cluster, which displays increased histone acetylation. Following DJ H rearrangement, the 
proximal portion of the V H locus becomes transcriptionally and recombinationally 
activated. This activation is accompanied by increases in histone acetylation levels in 
this region of the locus. Concomitantly, the heavy-chain locus becomes localized to a 
more centralized location (i.e. moves away from the nuclear lamina) in the nucleus via 




Reddy et al., 2008).  Cells are now at the proB cell stage and continued development 
and survival is dependent on the cytokine interleukin-7 (IL-7) (Carvalho, Mota-Santos, 
Cumano, Demengeot, & Vieira, 2001; Dias, H  Jr., Cumano, & Vieira, 2005; Miller et al., 
2002).  IL-7 signaling activates Stat5 (signal transducer and activator of transcription 5), 
which induces increased histone acetylation at the distal portion of the V H locus leading 
to transcriptional upregulation and recombination to these segments (Bertolino et al., 
2005; Kosak et al., 2002; Reddy et al., 2008). Pax5 (paired box 5) and Ezh2 (enhancer 
of zeste 2) are also upregulated at the proB cell stage. Pax5 and Ezh2 regulate histone 
methylation of H3K9 (histone H3, lyine 9) and H3K27 (Histone H3, lysine 27), 
respectively, leading to the activation of the locus (Johnson et al., 2004; Su et al., 2003). 
Pax5 and Ying Yang 1 (YY1) also contributes to more global changes at the locus 
leading to long-range locus contraction with another unidentified B cell factor (Fuxa et 
al., 2004).  Collectively, these changes allow V-to-DJ H recombination and commitment 
to the B cell lineage. Though many questions remain, it is clear that the same signals 
that drive B cell development exert their control over heavy-chain recombination; thereby 
ensuring that recombination of the immunoglobulin locus is both lineage specific and 
developmentally regulated. Importantly, these same transcriptional regulators also 
impact the three dimensional organization and architecture of the Igh locus.  
Specifically, it has been shown by us and others, using 3D-ImmunoFISH, that 
germ-line immunoglobulin heavy chain loci (Igh) are preferentially localized to the 
nuclear lamina in hematopoietic progenitors, T lineage cells and non-B cells (such as 
fibroblasts) but centrally positioned in proB cells, where they are active (Kosak et al., 
2002; Reddy et al., 2008; Yang, Riblet, & Schildkraut, 2005; Zhou, Ermakova, Riblet, 
Birshtein, & Schildkraut, 2002). Importantly, the inactive, lamina-proximal, Igh alleles in T 
cells do not co-localize with pericentromeric heterochromatin. Reddy et al, hypothesized 




nuclear periphery in non-B lineage cells renders them inactive for transcription and DNA 
recombination (Reddy et al., 2008). Additional studies have revealed an exquisite three 
dimensional choreography of the immunoglobulin loci during B cell development. Using 
mutations for transcription factors necessary for B cell development, it has become 
evident that not only is transcriptional activation/regulation of these loci dependent upon 
key developmental regulators, but so is the positioning of the Ig loci relative to different 
nuclear compartments (specifically the nuclear lamina/INM and centromeric 
heterochromatin). It however, remains largely unknown what factor(s) mediate 
repositioning of the Ig loci and if it’s dynamic organization to different nuclear 
compartments serves a regulatory role. Moreover, while the Igh locus is relatively well 
studied, virtually nothing is known about other important loci are regulated in a similar 
manner during B cell development. 
As mentioned previously, analyses of LADs domains revealed that they are 
enriched in silent genes (Guelen et al., 2008). Indeed, the entire 3 megabase Igh locus 
comprises an entire LAD in cell types in which the locus is inactive (i.e. fibroblasts) and 
is non-lamina associated in pro-B cells when the locus is active. We and others have 
uncovered numerous other LADs that change upon developmental progression (Zullo et 
al., 2012, Harr et al., 2015; Peric-Hupkes et al., 2010). We have named these LADS that 
change their configuration between cell stages or cell types vLADs for ‘variable’ Lamin 
Associated Domains. While initial studies have been done to map the genome-wide 
association of these vLADs regions with changes in epigenetic and transcriptional 
states, to truly assay the functional regions and consequences of nuclear scaffolding an 
assay must be developed to test these correlative studies (Peric-Hupkes et al., 2010). 
Given that the majority of LADs remain the same from cell type to cell type, it is 
imperative to focus on those regions that change upon developmental progression to 




association/dissociation of chromosomal domains from LADs impacts chromatin or 
transcriptional status of genes within those regions. While the entire Igh LAD is lost from 
pro B cells to fibroblasts, in most cases we note that variable LADs are a loss of the 
border regions, where the edge of the LAD appear to peel back and reveal the 
developmentally regulated genes (see Chapter 2 for more detail).  
 
1.6: Functional and dynamic organization of LADs in development and cellular 
function 
The Igh locus and other developmentally regulated genes that display variable 
lamina association dependent on cell state lead us to hypothesize that the nuclear 
periphery can act as a functional compartment to specifically regulate gene activity. 
What is not known is how these genes and other regions are recruited or directed to this 
region of the nucleus and their properties once resident there. When deciphering 
information gained by cytological and genome-wide studies, it is important to note that it 
is unknown whether LADs identified by DamID or other means are actually scaffolded at 
the INM/lamina or whether they represent a population sequestered to a more peripheral 
region. As previously mentioned, recent live cell studies in cancerous cell lines 
demonstrated that LADs are dramatically and dynamically repositioned after transiting 
the cell cycle, even well away from lamina-proximal positions (Kind et al., 2013). Given 
the experimental limitations of these techniques (overexpression of the Dam-LMNB1 
fusion protein and the use of a highly transformed cell line), it is unclear whether these 
long range and apparently stochastic movements are a property of normal LAD 
organization and dynamics. Aside from these limitations, these studies uncovered an 
interesting phenomenon occurring at the nuclear periphery—an apparent stochasticism 
and dynamics within what we have termed, the ‘peripheral zone’. Studies in developing 




and expressed at very low levels (Yao et al., 2011), support the concept of a peripheral 
zone. In these studies, the MyoD locus was retained in the peripheral region until 
activation/differentiation. Specific exclusion of the core transcription factor TAF3 away 
from the zone at the periphery was demonstrated to be important for the relative 
inactivity of the MyoD1 locus in early myogenesis and H3K9me3 was demonstrated to 
be enriched in this same zone. Interestingly, artificially tethering a Myod1 promoter 
transgene to the nuclear periphery results in total transcriptional repression of the 
transgene, raising the provocative possibility that protein-lamina tethering and 
localization to the peripheral zone both serve to regulate gene activity, but to differing 
degrees (Yao et al., 2011). As mentioned previously, numerous other studies have 
shown interactions of chromatin modifiers and scaffolding proteins at the periphery, for 
example HDAC3 interactions with Lap2β, HP1 with LBR and BAF with numerous INM 
proteins and chromatin (Berk, Tifft, & Wilson; Ada L Olins et al.; Zullo et al., 2012). As 
demonstrated by the regulation of the MyoD1 gene and as discussed previously for the 
differential roles of LBR (See, 1.1: The nuclear periphery and chromosome 
organization), compositional changes in the IMN protein and or nuclear lamina network 
likely have effects on gene regulation and chromatin scaffolding.  
This raises the question of how a genic region might be directed to or away from, 
the nuclear periphery. While evidence supports that gene activation and movement 
away from the nuclear periphery are coupled, it is currently unclear whether activation 
precedes movement away from this repressive domain, and this is an area of current 
investigation (Hübner, Eckersley-Maslin, & Spector, 2013; Kumaran & Spector, 2008; 
Noordermeer et al., 2011; Peric-Hupkes et al., 2010). No LAD ‘zipcode’ has yet been 
identified and it is important to note that there are different types of LADs—those that 
change their LAD status upon differentiation or cell state changes (vLADs or variable 




constant LADs). It is evident that cLADs and vLADs exhibit different responses to 
developmental cues and, thus, not all LADs are equal. Additionally, it is in the vLAD 
regions that we see an enrichment of developmentally regulated genes, and we 
therefore hypothesize that these regions play a special role in gene regulation. It will 
therefore be important to analyze vLADs specifically to uncover sequences and 
mechanisms that allow for regulated and directed reorganization of genic regions in a 
cell type specific manner. As an example, a collaborative study in our lab focused on the 
Igh and Cyp3a loci which are lamina-proximal in murine fibroblasts but nucleoplasmic in 
both pro-B cells and hepatocytes (Zullo et al., 2012). In these studies, Lamina 
Associated Sequences (LASes) from these vLAD regions were identified that were able 
to direct repositioning of ectopic regions to the nuclear periphery when randomly (and 
iteratively) integrated into the genome of fibroblasts—a cell type in which the 
endogenous genes are normally inactive and lamina-proximal (Zullo et al., 2012). These 
iterated copies of LASs can be thought of as potential lamina ‘zipcodes’. The LAS 
sequences identified were enriched in GA di-nucleotides, which is striking given that 
LAD domains are relatively A/T rich. It is tempting to speculate that such LAS sequences 
may be important for establishing peripheral compartmentalization of genomic regions 
during cellular differentiation. It is, however, still unclear how decisions pertaining to cell 
type specific LADs are being made given an (almost) identical genome across cell types 
of an organism. It will be necessary and we aim to uncover more such LAS elements 
from vLADs, to determine whether such sequences are truly sufficient and what proteins 
mediate reorganization into a de novo LAD.  
The above mentioned work also uncovered a role for the cell type specific 
transcription factor (Zbtb7b), a histone deacetylase (HDAC3) and an INM protein 




POZ domain protein that recognizes GA(n) sequences and can act as both a 
transcriptional repressor or activator (Melnick et al., 2002). Another BTB-POZ domain 
protein, mGCL (murine Germ-Cell-Less, also a transcriptional repressor) interacts with 
Lap2β and Emerin in the INM, suggesting the intriguing possibility that this large family 
of differentially and developmentally expressed proteins may play a role in LAD 
architecture and function (Kimura et al., 2003). In addition, the BTB-POZ domain has 
been shown to recruit PRC2 to chromatin. As previously mentioned YY1 also can 
interact with PRC2, mediating a similar event, leading to the possibility that that targeting 
of LASes by these proteins leads to H3K27me3 as well as association with the nuclear 
periphery (Boulay et al., 2012). In further support for this model, in Drosophila neurons, 
the neural competence factor hunchback (Hb) becomes repressed and lamina-proximal 
concurrently with down-regulation of Distal Antenna (Dan) (Kohwi, Hiebert, & Doe, 
2011). Dan contains a ‘pipsqueak’ GAGA DNA binding motif that competes with BTB-
POZ domain proteins for its target sites, and expression of Dan prevents the lamina-
proximal positioning and repression of Hb (Lehmann, Siegmund, Lintermann, & Korge, 
1998). It is hypothesized that LAS containing regions recruit specific factors (e. g. Zbtb7b 
or Dan) that in turn either promote (Zbtb7b) or inhibit (Dan) association with the nuclear 
periphery. In addition, these cell type specific transcription factors could recruit 
chromatin remodelers [or interact with proteins, such as YY1 that recruit modifiers 
(PRC2), see Chapter 2 for further discussion] for the induction of large scale chromatin 
changes concurrent with either localization to or away from the nuclear periphery. 
Moreover, epigenetic state may be the overriding factor in the ‘decision’ to be relegated 
to the peripheral zone and LAS sequences with specific protein partners may merely act 
as a molecular switch for inducing a specific chromatin signature that drives the 
reorganization of specific regions to the repressive nuclear periphery. In either case, it 




on top of the LAS sequences is needed to discriminate between domains that remain 
nucleoplasmic and those that are destined to become LADs in a cell type specific 
manner. It is likely that more cell type specific factors (both the previously mentioned 
NETs and transcriptional regulators) will be identified in regulating the dynamic LAD 
landscape, both in development and disease.  
 
1.7: Imaging of Nuclear Dynamics 
1.7.1: Insights into Chromosome Dynamics Using Live Cells: The LacO System 
As outlined above, the search for the mechanisms underlying nonrandom 
chromosome and gene organization within the nucleus, particularly scaffolding at the 
nuclear lamina, as well as the functional consequences of such a configuration lies at 
the heart of research into nuclear dynamics. In order to determine such 
structure/function relationships, a manipulable live cell synthetic genomic locus would be 
the ideal test system for such studies. The LacI/lacO system has been widely used in 
mammalian cells to study chromosomal dynamics and chromatin decondensation. 
These arrays can also be used to visualize a chromosomal domain and its movements 
in living cells under many conditions (Figure 1.2). Previous studies have demonstrated 
that LacI binds to lacO sites with high affinity (Kd = 10-10) and DNA binding is reversed 
upon incubation with the allosteric inhibitor isopropyl b-D-1-thiogalactopyranoside [IPTG 
(Cronin, Gluba, & Scrable, 2001; Dong et al., 1999)]. Importantly, in mammalian cells a 
fluorescently tagged LacI protein is able to bind to integrated lacO sites (256 copies) 
specifically and can be visualized using simple live cell microscopy techniques (Belmont, 
Li, Sudlow, & Robinett, 1999). Thus, this system provides for highly specific and stable 
DNA binding that is reversible using a relatively inexpensive reagent (IPTG). These 








Figure 1.2: Stably integrated arrays of lacO binding sites are visible upon binding of 
GFP-LacI in living cells. Shown are cells containing the lacO repeats that are also 
expressing GFP-LacI. This interaction is controlled by the allosteric inhibitor IPTG. IPTG 
can be used in the culture medium to prevent GFP-LacI from binding (+IPTG). Upon 
IPTG withdrawal (IPTG), accumulation of the GFP-LacI protein on the lacO arrays 
occurs in a matter of hours. This system has been widely used to look at chromosomal 
domain dynamics (several megabases) with large amplified regions of lacO repeats or 





dynamics of large amplified arrays of lacO binding sites occupying megabases of DNA 
as well as more discreet regions comprising only one or two sites of integration (10 kb; 
(Belmont et al., 1999). These integrated arrays have been demonstrated to exhibit 
simple Brownian motion in interphase nuclei and the larger (Mb) sized integrations, are 
quite often condensed and heterochromatic (Belmont et al., 1999; Tumbar, Sudlow, & 
Belmont, 1999). Upon binding of a transcriptional activator to these large designer 
chromosomal domains, the decondensation of the domain is dramatic and easily seen 
by light microscopy (Tumbar et al., 1999). In addition, a random integration positioned 
reproducibly at the nuclear periphery shows dramatic relocalization to the nuclear interior 
upon trans-activation along with rapid and apparently directed movements (Tumbar et 
al., 1999). Finally, the extent of movement of individual tagged chromosomal domains 
varies depending upon their nuclear environment; specifically, chromosomal domains 
located at the nuclear periphery or chromocenters move in a smaller diameter than 
those regions located in the nuclear interior. Taken together, such studies demonstrate 
the utility of using tagged chromosomal domains in living cells to study the interplay of 
chromosome dynamics and gene regulation in space and time. 
 
1.7.2: Forced Repositioning of Chromosomal Domains Using Molecular Tethers in Living 
Cells: Insights into Consequences of Repositioning 
More recently, the lacO system has been used to position integrated test genes 
to the inner nuclear membrane and to test the consequences of such repositioning on 
gene activity [Figure 1.3; (Finlan et al., 2008; Kumaran & Spector, 2008; Reddy & Singh, 
2008)]. Three studies took advantage of targeting strategies using lacO sites positioned 
either well upstream or downstream of a test gene to avoid inhibition of transcription due 
to binding of LacI fusion proteins (Finlan et al., 2008; Kumaran & Spector, 2008; Reddy 







Figure 1.3: Three different strategies expand upon the original lacO/LacI system to 
tether chromatin domains to the INM/Lamina. The top two panels demonstrate similar 
strategies using an INM protein. In the topmost panel, a truncated version of Emerin, 
delta Emerin, fused to LacI was used to reversibly interact with chromosomal domains 
(Reddy et al., 2008). In the middle panel, the INM protein L2b was used as the molecular 
tether to recruit lacO sites (Finlan et al., 2008). In both cases binding was able to be 
controlled by introducing the allosteric inhibitor IPTG. In the bottom panel, a cumate 
inducible LaminB1-LacI fusion was used to tether lacO insertions to the nuclear lamins 






the INM/lamina using either a portion of the resident INM proteins (Emerin or Lap2β) or 
the nuclear lamina protein Lamin B1. In both studies using INM protein domains, the 
chimeric proteins were stably expressed in cells and they resulted in the recruitment of 
the target lacO containing chromosomal domains to the INM upon removal of IPTG 
(Finlan et al., 2008; Kumaran & Spector, 2008; Reddy et al., 2008). In the case of the 
Lamin B1-LacI chimeric fusion, the protein itself was inducibly expressed and was not 
regulated by IPTG. In all cases, the lacO insertions were reproducibly recruited to the 
nuclear periphery, allowing, for the first time, a study of the consequences of forced 
compartmentalization. The two studies utilizing INM proteins (Emerin and Lap2β) as 
tethers resulted in transcriptional repression accompanied by changes in chromatin 
status around the recruited domain (Finlan et al., 2008; Kumaran & Spector, 2008; 
Reddy et al., 2008). Intriguingly, the study using Lamin B1 focused on the kinetics of 
gene induction of a reporter gene tethered to the nuclear lamina (Kumaran & Spector, 
2008). The activity of this reporter gene, encoding the cyan fluorescent protein (CFP) 
and containing MS2-RNA repeats in the intron of the nascent RNA which can be 
recognized by MS2-YFP protein, allows for visualization of gene activity in individual live 
nuclei. For this reporter system activity levels were measured either by CFP 
fluorescence or MS2-YFP accumulation at sites of nascent transcription (Kumaran & 
Spector, 2008). These forced tethering studies also uncovered a potential link between 
progression through the cell cycle and recruitment to the nuclear lamina. These 
observations would never have been made using molecular or fixed cell approaches. 
These adaptations of the original LacI/lacO system demonstrate the versatility of using 
live cell systems to discover not only dynamics of nuclear architecture but also 





1.7.3: The Future: Induced Repositioning of Chromosomal Domains Using ‘Nuclear 
Zipcodes’ or Specific trans-Factors Identified by Genome-Wide/Molecular Analyses 
How is the architecture of a nucleus set up? This is one of the big questions in 
the field of nuclear dynamics. The studies detailed above describe artificial systems 
where genic regions are ‘forced’ to associate with a nuclear domain by molecular 
tethers, specifically the INM/nuclear lamina and, thus, did not address this basic 
question. In addition, Dam-ID studies have indicated sequences that are in high-
frequency association with this domain (Guelen et al., 2008; Peric-Hupkes et al., 2010). 
Thus, the preferential association of a genomic region with this structure affords the 
unique opportunity to uncover the role that specific DNA elements have in determining 
genome organization. By definition, such cis-elements or nuclear ‘zipcodes’, would direct 
or facilitate association of chromosomal domains with a specific nuclear compartment. 
Using data generated by genome-wide approaches, potential DNA elements can be 
tested for their ability to direct nuclear compartmentalization (see Chapter 2, Harr et al., 
2015; Zullo et al., 2012). The advantage of using such a system is that the elements 
tested would be subject to the normal cell cycle and other cellular controls involved in 
establishing nuclear architecture – a feature missing from the forced association studies 
using molecular tethers described above. One can imagine two ways to test the ability of 
cis-elements to reposition an ectopic site to a new position in the nuclear volume in living 
cells. First, one could simply randomly integrate these elements with lacO sites and 
assay the frequency of association with a given compartment (e.g., the nuclear lamina) 
by looking at GFP-LacI foci by light microscopy. Unfortunately, such an approach yields 
multiple integrations and different sites for each different sequence tested, making any 
conclusions about repositioning suspect. Moreover, since there is no control over where 





 A better strategy would employ a system that allowed for directed insertion of 
the cis sequences to be tested into the same chromosomal location. An example of a 
modification of such a system that has been demonstrated to work in this way is shown 
in Figure 1.4. This tagged chromosomal insertion site (TCIS) system incorporates the 
ability to tag a chromosomal region via the lacO/LacI system and to recombine specific 
sequences into the same location using recombination-mediated cassette exchange 
(RMCE), a well-documented method for site-specific integration of DNA sequences [see 
chapter 3 for a more detailed description and methodology, (Belmont et al., 1999; Feng 
et al., 1999)]. The TCIS system represents a rapid way to assay DNA elements for 
nuclear disposition and activity. Moreover, since multiple sequences are tested within 
the same nuclear environment, data artifacts due to position effects are avoided.  
In addition to using live cells to study the mechanism by which cis- or trans-
elements (protein interactors) are able or sufficient to cause a chromosomal domain to 
reposition to a new nuclear domain, live cells can also be used to detect the molecular 
association of engineered chromosomes with a protein present in a given nuclear 
compartment. BiFC allows the direct visualization of protein complexes in their native 
environment. BiFC is based on the formation of a fluorescent protein from two 
nonfluorescent constituents (Kerppola, 2008). Specifically, BiFC employs a strategy that 
splits either GFP or YFP into two domains (an N- and a C- terminal portion) that can 
complement one another to form a fluorescent protein, but individually have no 
fluorescence. The two domains only fluoresce when they are brought into close 
molecular proximity to one another, for example, when they are fused to two proteins 
that interact with one another. Coupling this technology with the lacO/LacI system should 
enable detection of such nuclear events as chromosome looping and 
compartmentalization by fusing one-half of the BiFC to LacI and the other half to either a 




Figure 1.4: Newer uses of the lacO/LacI system. (A) A new system has been designed 
to allow for integration of ‘nuclear zipcodes into a specific genomic site. This is 
accomplished by flipping the sequence of interest into an engineered chromosome 
region containing inverted loxP sites adjacent to lacO sequences. In the absence of a 
sequence that is able to direct compartmentalization, the array is located in the nuclear 
interior (nucleus at top). After introducing a targeting sequence containing a putative 
nuclear zip code, the array is now preferentially located at the nuclear periphery (nucleus 
at the bottom). Analysis using BiFC (see below) or expression from a test gene can be 
incorporated into this system to garner positional, molecular and regulatory information. 
(B) Design of a system to detect molecular interaction of a genomic region with a nuclear 
compartment. The basic concept of BiFC is illustrated in the box in panel (B). LacI is 
fused to one-half of fluorescent YFP and a protein located in a nuclear subcompartment 
is fused to a cognate half of the YFP molecular. If the two proteins are in molecular 
proximity, a complete fluorescent YFP will be formed. A nuclear zipcode is used (as is 
(A)) to direct a sequence to a subnuclear domain. The LacI fusion protein bound to lacO 
repeats will be directed to the compartment and will be brought into proximity to allow for 
formation of the fluorescent protein. The type of analysis allows one to get specific real 





example, the nuclear lamina (Figure 1.4 and see Appendix I). BiFC has been used quite 
successfully to demonstrate novel dynamics of the protein CBX binding to chromatin 
(Vincenz & Kerppola, 2008). CBX recruits the polycomb repressive complex 1 (PRC1) 
and is very important in establishing heterochromatin domains. Numerous previous 
studies relied on immunofluorescence to detect CBX proteins; however, such a strategy 
is unable to detect whether the protein is actually interacting with chromatin. Of course, 
ChIP can detect specific chromatin interactions, but those studies lack spatial 
information. Using BiFC to CBX and histones, the patterns of chromatin interacting 
versus total CBX were quite distinct (Vincenz & Kerppola, 2008). Thus, BiFC allows 
measurement of spatial, contextual, and temporal changes in protein complexes and will 
likely be an important tool in detecting the dynamics of nuclear compartmentalization. 
Live cell imaging techniques are poised to take advantage of the many genome-
wide molecular assays that are currently being employed to describe genome-wide 
nuclear associations to uncover the mechanisms and consequences of nuclear 
architecture and organization on gene activity. Using the well-established lacO/LacI 
system and other techniques such as BiFC and nascent RNA detection methods in living 
cells will enable spatial, temporal, and molecular analysis to be carried out in a single 
cell giving an unprecedented view of form and function of nuclear dynamics. 
 
1.8: Summary  
The work described in subsequent chapters demonstrates the use of genome 
wide data, generated by Dam-ID, to identify specific regions of the genome that are 
variably associated with the nuclear periphery (variably lamina associated domains, 
vLADs) that are enriched for developmentally regulated genes. We propose that these 
vLADs play a key role in regulating cell type specific genes that are involved in 




maintenance at the nuclear periphery, we utilized the TCIS system in murine fibroblasts 
to determine DNA sequences sufficient to target to the nuclear periphery and therefore 
reorganize chromatin. Through this investigation, which is presented in Chapter 2, we 
further identify proteins involved in this process, including Ying-Yang-1 (YY1), BTB/POZ 
domain binding proteins and polycomb repressive complex 2 (PRC2) and the 
importance of at least two histone modifications, H3K27me3 and H3K9me2/3, in 
mediating this process. We describe the development of a novel tool for studying both 
DNA elements and their protein partners involved in nuclear compartmentalization, the 








 Directed targeting of chromatin to the nuclear lamina 













This work was done in collaboration with Teresa Luperchio, Xianrong Wong, Erez 
Cohen, Sarah J. Wheelan, and Karen L. Reddy. It was published in The Journal of Cell 





Nuclear organization has been implicated in regulating gene activity. Recently, 
large developmentally regulated regions of the genome dynamically associated with the 
nuclear lamina have been identified. However, little is known about how these lamina-
associated domains (LADs) are directed to the nuclear lamina. We use our tagged 
chromosomal insertion site system to identify small sequences from borders of 
fibroblast-specific variable LADs that are sufficient to target these ectopic sites to the 
nuclear periphery. We identify YY1 (Ying-Yang1) binding sites as enriched in relocating 
sequences. Knockdown of YY1 or lamin A/C, but not lamin A, led to a loss of lamina 
association. In addition, targeted recruitment of YY1 proteins facilitated ectopic LAD 
formation dependent on histone H3 lysine 27 trimethylation and histone H3 lysine di- and 
trimethylation. Our results also reveal that endogenous loci appear to be dependent on 




Recent evidence suggests that nuclear architecture influences gene regulation 
through establishment of large chromatin domains and through enrichment of regulatory 
and structural proteins within these regions (Misteli, 2005; Scaffidi and Misteli, 2006; 
Cremer et al., 2001, 2006; Fedorova and Zink, 2008; Elcock and Bridger, 2010; Ferrai et 
al., 2010; Van Bortle and Corces, 2012). One such domain, the nuclear periphery, is 
comprised of the inner nuclear membrane, resident inner nuclear membrane proteins, as 
well as underlying nuclear lamina and associated proteins. This region has been 
implicated in gene regulation, and various studies demonstrate that recruitment of genic 
regions (lamina-associated sequences [LASs]) to the nuclear periphery is sufficient to 




2008; Zullo et al., 2012). More recently, molecular mapping of large chromatin regions in 
molecular contact with the nuclear periphery by DNA adenine methyltransferase (Dam) 
identification (DamID) has identified large lamina-associated domains (LADs; 0.1–10 
Mb) that dynamically associate with the nuclear lamina (Guelen et al., 2008; Peric-
Hupkes et al., 2010). Moreover, cell state–specific association with the nuclear lamina 
appears to be involved in repression of many developmental genes, including the 
immunoglobulin heavy chain (Igh) locus (Kosak et al., 2002; Yang et al., 2005; Williams 
et al., 2006; Szczerbal et al., 2009; Meister et al., 2010; Peric-Hupkes et al., 2010; Yao 
et al., 2011; Lin et al., 2012). More recently, both LMNA (lamin A) and lamin B receptor 
have been implicated in tethering heterochromatin to the nuclear lamina in rod 
photoreceptor cells in nocturnal animals (Solovei et al., 2013). LADs have been reported 
to be repressive domains enriched in histone H3 lysine 9 di- or trimethylation 
(H3K9me2/3; Guelen et al., 2008; Wen et al., 2009; Towbin et al., 2012). In addition, two 
recent studies have implicated H3K9me2/3 in the positioning of chromatin at the nuclear 
lamina in murine cells and in Caenorhabditis elegans (Towbin et al., 2012; Bian et al., 
2013). Intriguingly, the borders of LADs appear to be enriched in both H3K9me2/3 and 
H3K27me3 (histone H3 lysine 27 trimethylation) as well as CCCTC-binding factor 
(CTCF) binding sites; however, a role for the chromatin state found enriched in these 
regions in establishment and/or maintenance of LAD organization has not been 
thoroughly investigated (Guelen et al., 2008; Zullo et al., 2012; Meuleman et al., 2013; 
Van Bortle et al., 2013). It is of special note that these LAD borders, enriched in 
H3K27me3 and flanked by CTCF binding sites, are quite sharp and well delimited, 
suggesting an active mechanism to continually reestablish and maintain these regions. 
Because many of the developmentally regulated variable LADs (vLADs) between cell 
types occur by shifting these LAD border regions, we hypothesized that the study of 




genome is reorganized at the nuclear periphery (Figure 2.1; Peric-Hupkes et al., 2010). 
We therefore sought to elucidate factors and genic elements involved in positioning of 
chromatin to the nuclear periphery in mammalian cells, with a particular focus on 
dynamically reorganized border regions of LADs. This work identifies genomic regions 
containing developmentally regulated genes that reside in regions that are dynamically 
lamina associated depending on cellular state (vLADs) and, therefore, have regulated 
nuclear positioning. We have identified vLADs covering the Ikaros (Ikzf1) and B cell 
CLL/lymphoma 11A (Bcl11a) loci, which are positioned at the border of fibroblast (FB)-
specific vLADs and are no longer associated with the lamina in pro–B cells. We have 
developed and used our tagged chromosomal insertion site (TCIS) system to examine 
single DNA sequences from these vLAD border regions for their ability to target and 
scaffold chromatin to the nuclear periphery. This approach has led to the discovery of a 
role for LMNA/C, YY1, H3K27me3, and H3K9me2/3 for targeting to the nuclear lamina of 




2.3.1: Developmental and cell type–specific genes are enriched in vLADS 
The Igh locus, which itself comprises a vLAD, is lamina proximal and inactive in 
FB but is centrally disposed and active in pro-B cells where it is transcriptionally and 
recombinationally active (Figure 2.1 A; Reddy et al., 2008). We hypothesized that there 
would be other vLADs between FB and pro–B cells that contain developmentally 
regulated genes. To determine whether such regions exist, we detected in vivo lamina–
genome interactions by performing DamID in pro–B and FB cells (see Materials and 
methods; Vogel et al., 2007; Reddy et al., 2008). We determined LADs to be contiguous 






Figure 2.1: Both FB and proB cell genomes contain vLADs. (A-D) Shown are regions 
containing the Igh, Ikzf1 and Bcl11a loci from FB specific vLADs. Left, representative 
images of 3D DNA ImmunoFISH of endogenous in FB and proB cells.  FISH probes 
detecting the indicated regions (arrowhead) and the nuclear lamina is demarcated by 
LMNB1 (red). Middle, quantitation of peripheral association was determined by overlap 
of FISH probe and LMNB1 (n ≥ 50). Right, DamID detection of LADs log2(Dam-
LMNB1/Dam) average ratios from three experiments for FB (blue) and proB cells 
(orange). Traces above the zero line indicate a region in a LAD. Solid blue and orange 
bars underscore LADs in FB and proB cells, respectively. Genes are indicated as 
transcripts (blue) our gene of interest is red, BAC locations are indicated by green bars 





background control, Dam only (log2 [Dam-LMNB1/Dam]), in mouse embryonic FBs 
(MEFs) and proB cells (Figure 2.1, solid heavy blue or orange lines under histograms 
denote identified LADs; see Materials and methods; Venkatraman and Olshen, 2007; 
Zullo et al., 2012). These data are in agreement with previously published LAD data for 
MEFs (Figure 2.2 A; Peric- Hupkes et al., 2010). In agreement with a previous study, we 
identified numerous vLADs between FB and proB cells that contain key developmental 
and cell type–specific genes (Figure 2.1; Peric-Hupkes et al., 2010). For this work, we 
focused on genes that were resident in LADs in FB but were not lamina-proximal in pro–
B cells.  
Not surprisingly, we demonstrate that the Igh locus is contained within one of 
these vLADs (Figure 2.1 A; Reddy et al., 2008; Zullo et al., 2012). In addition, we have 
also determined that the key B cell development genes Ikzf1 and Bcl11a are contained 
within FB-specific vLADs (but not in proB cells) as determined both by immuno-FISH 
and DamID protocols, consistent with their (active) roles in B cell development (Figure 
2.1, B and C; and Figure 2.2 A). Therefore, these regions are ideal candidates for 
interrogating sequence-dependent mechanisms of positioning to the nuclear lamina. We 
also identified a region spanning the Dnmt3a gene, which is not in a LAD, but inactive 
(by array and quantitative PCR [qPCR] analyses), in our cell lines (Figure 2.1 D). 3D 
immuno-FISH analyses confirmed that the disposition of these endogenous genomic 
regions in MEFs and proB cells are as expected (Figure 2.1). It is important to note that 
the loci/regions we have identified in MEFs as lamina proximal by DamID are at the 
nuclear periphery in a majority of FB (65–80% have both alleles at the lamina), whereas 
these same regions display negative lamina association by DamID and an association 
rate of 30% in proB cells, reflecting the background level of “association” with the lamina 
by cytological measures. Both of these cell types are primary cells and may display 





Figure 2.2: Lamin associated domains, as determined by DamID compared in three cell 
types. (A) A 20kb window shows that FB Dam-ID traces (blue) align with previously 
published data from this region (purple, Peric-Hupkes, 2010 GEO: GSE17051). DamID 
data is represented by log2(Dam-LMNB1/Dam) average ratios from three experiments, 
shown for FB (blue) and proB cells (orange). Traces above the zero line indicate a 
region in a LAD. Mouse Rag-/-  proB cells (orange) and Mouse Embryonic Stem cells 
(green, Peric-Hupkes, 2010 GEO: GSE17051) highlight the presence of Ikzf1 and 
Bcl11a in FB specific vLADs (vLADs shaded in gray). Solid blue and orange bars are 
bioinformatically determined binary LAD calls for FB and proB cells, respectively. Genes 
are indicated as transcripts below the traces (blue). (B) BACs to the LAD border regions 





published from subcloned cancer-derived cell lines (Kind et al., 2013). Finally, gene 
expression microarray data from proB cells and FB demonstrate differential expression 
levels for Bcl11a, Ikzf1, and Igh, in agreement with previous studies and consistent with 
the nuclear lamina facilitating or reflecting a transcriptionally repressed state 
(unpublished data; Medina and Singh, 2005; Johnson et al., 2008, 2009; Reynaud et al., 
2008; Heydarian et al., 2014). 
Interestingly, we have noted that many vLADs are at LAD borders, suggesting 
that these regions may be especially important in dynamic genome reorganization 
(Peric-Hupkes et al., 2010 and unpublished data). The Igh locus is unusual in that the 
locus itself comprises the LAD (3 Mb) and the entire LAD reorganizes in proB cells, 
whereas Ikzf1 and Bcl11a are more typical examples of vLADs, with only a portion of the 
LAD (proximal to the border) being lost in the permissive proB cell type (Figure 2.1). 
 
2.3.2: DNA sequences from vLAD borders target to the nuclear periphery 
To elucidate the ability of specific LASs to direct targeting of sequences to the 
nuclear periphery, we integrated bacterial artificial chromosome (BAC) DNA constructs 
carrying sequences from FB-specific vLAD border regions covering the Ikzf1 (RP23-
349M24) and Bcl11a (RP23-30C14 and RP23-153C18) loci into the genome of NIH3T3-
derived C57BL/6 FB (ATCC CRL-2752; Figures. 2.2 B and 2.3, A and B). As controls, a 
BAC from the distal, but internal, portion of the Igh locus (lamina-associated positive 
control, RP23-123N21) and another covering the Dnmt3a locus (non-lamina-associated 
negative control, RP23-364H6) were also used (Figures 2.1 and 2.3; Zullo et al., 2012). 
These BACs were randomly co-integrated into FB cells with hygromycin-selectable lacO 
arrays, as previously described (Zullo et al., 2012). The lacO arrays serve as docking 
sites for EGFP-LacI, thus enabling quick identification by microscopy of the disposition of 










Figure 2.3: Bacterial Artificial Chromosomes (BACs) covering developmentally 
regulated vLAD borders target to the nuclear periphery. (A) Representative images of 
random co-integration of BACs and lacO arrays. Arrowheads indicate the lacO array 
location as detected by EGFP-LacI binding. LMNB1 (red) marks the periphery of the 
nucleus. Inset is a 300X magnification of the EGFP-LacI focus (B) Quantitation of 
peripheral association was determined by overlap of EGFP-LacI focus and anti-LMNB1 
signal (n ≥ 50, P≤ 0.001). The dotted line indicates the frequency that a non-targeting 
sequence associates with the nuclear periphery (lacO arrays) Error bars indicate SD of 
two experiments by two individuals. (C) DNA fragments covering the border region of the 
FB specific Bcl11a vLAD contain LADed and non-LADed regions. Most of these 
fragments do not cover the Bcl11a gene. Histogram traces are log2(Dam-LMNB1/Dam) 
and consecutive positive signal indicates a LAD region in FB. Solid blue bars represent 
binary LADs calls. The Bcl11a locus (dark blue) is shown above the LAD call and the 
position of the RP23-153C18 and RP23-30C14 BACs used to generate the smaller 
fragments are shown in green. Smaller DNA fragments tested for repositioning are 
shown in pink (generated from the RP23-153C18 BAC) and orange (generated from the 
RP23-30C14 BAC). (D) Quantitation of random integration of the indicated DNA 
fragments (orange) from BAC RP23-30C14 in C57BL/6 FB (n ≥ 50, p≤ 0.001). Error bars 
are the D of imaging data as scored by two individuals. (E) Quantitation of IF data from 
TCIS clones Y (black) and 12 (gray) after switching the indicated DNA fragments (pink) 
contained within BAC RP23-153C18. TCIS-NS are the TCIS clones Y and 12 containing 






Figure 2.3: Bacterial Artificial Chromosomes (BACs) covering developmentally 





as peripheral (Figure 2.3, A and B). lacO arrays integrated alone served as a control for 
expected distribution of random integrations, and these were found at the periphery with 
a frequency of 30% (Figure 2.3 B). Importantly, an integrated BAC covering the Dnmt3a 
locus is centrally disposed despite its inactive status, reminiscent of the disposition of the 
endogenous locus (Figures 2.3 B and 2.1 D). We note that a previous study showed that 
the genomic region around the neuronal PAS domain 3 gene (NPAS3) was not in a LAD 
in FBs (though inactive) and was unable to reposition an ectopic site in this cell type, in 
agreement with our results for the genomic region around Dnmt3a (Zullo et al., 2012). 
Moreover, NPAS3 is in a LAD in proB cells (unpublished data; GEO accession no. 
GSE56990). These data suggest that, perhaps, sequences from domains that are not in 
an FB LAD are unable to confer lamina-proximal association in FB, regardless of 
transcription status or LAD status in alternate cell types. In contrast, BACs covering 
vLADs have a 60% (Bcl11a - 1) to 80% (Ikzf1, Bcl11a-2, and Igh) propensity to be 
lamina proximal, mimicking the disposition of endogenous loci (Figs. 2.1 and 2.3 B).  
Given that these BAC LAS are able to mediate association of ectopic sites to the 
nuclear lamina, we next asked whether we could elucidate smaller sequences capable 
of such targeting. Both the Ikzf1- and Bcl11a -containing BACs demonstrating potential 
to direct to the nuclear periphery were further fragmented (Ikzf1 (A–O); Figures 2.4 A 
and 2.3 C), and these smaller potential Ikzf1 LASs were randomly co-integrated with the 
aforementioned lacO arrays. The Ikzf1 fragments tested ranged from 900 bp to 30 kbp 
and were derived from regions interior to the vLAD border as well as those crossing and 
outside of the border regions (Figure 2.4, A–C , Ikzf1 (I) and (O)). Interestingly, the 
fragments seem to show repositioning potential that correlated with the LAD status of the 
endogenous region (Figure 2.4, B and C, gray bars). Noteworthy is the non-relocating 
Ikzf1 (F) whose sequence falls in a break, or dip, in lamina association in an otherwise 












Figure 2.4: Ikzf1 LAS target to the nuclear periphery in FB. (A) Ikzf1 (A-I, O) fragments 
span the border region of the FB specific Ikzf1 vLAD. Histograms are log2(Dam-
LMNB1/Dam) and the blue bar underscores the LAD. The Ikzf1 locus (blue) and 
overlapping BAC used to generate the smaller fragments are shown (green). Ikzf1 LAS 
are red, and non-associating fragments are gray. (B) Representative images of the 
showing the disposition of lacO arrays (arrowheads, green) and LMNB1 (red) in the 
original TCIS clone as well as nuclei harboring randomly integrated Ikzf1 BAC fragments 
(top panels) or TCIS clones with site-specific recombination of Ikzf1 (A, F, I, O) Inset, 
300X (C) Quantitation of peripheral association was determined by overlap of EGFP-
LacI foci and LMNB1 (n ≥ 50). Fragments were tested for their ability to target to the 
nuclear periphery by random integration (gray) or by directed integration (TCIS, black 
bars). Error bars indicate SD. p ≤ 0.001 (ƚ, random integration and *, TCIS switch). (D) 
Representative images of IF for the disposition of Ikzf1 (I) or Igh (N) LAS recombined 
into the TCIS sites in clones Y and 12. Arrowheads, EGFP-LacI binding lacO arrays 
(green) at the TCIS site, LMNB1 (red). Inset, 300X (E) Quantitation of peripheral 











outside of a LAD, and it does not relocate to the periphery (Figure 2.4, A–C, gray bars). 
We therefore hypothesize that Ikzf1 (O) lacks sequences sufficient to target (address) to 
the nuclear periphery, whereas the Ikzf1 (I) LAS retains this information. Similar results 
were obtained for the BAC containing sequences from the LAD border covering the 
Bcl11a locus (Figure 2.3 D). 
One caveat to this, and previously published experiments, is that the LASs tested 
have all been randomly integrated and likely represent many copies of the sequence at 
any given insertion site (Zullo et al., 2012; Bian et al., 2013). Therefore, it is difficult to 
determine whether an identified LAS was truly sufficient for targeting to the periphery or 
whether multiple copies of the LAS conferred a novel DNA or chromatin state that was it- 
self a signal for compartmentalization. Intriguingly, many LADs contain duplicated genes 
or loci, for example, the Igh and Cyp3a loci, and are enriched in long interspersed 
nuclear elements, suggesting that multimeric sequences may be a signal for directing to 
the lamina (Zullo et al., 2012). However, there are regions of the genome that do not 
appear to be highly duplicated that are in a LAD (e.g., Ikzf1 and Bcl11a LAD regions), 
and we therefore hypothesize that a single LAS may contain sufficient information to 
direct lamina-proximal targeting. 
 
2.3.3: LAS from vLAD borders are sufficient to target to the periphery 
To enable an experimental test of this hypothesis, we have developed a novel 
technique, TCIS, in which we can integrate a single DNA fragment of choice into the 
genome by directed recombination (Figure 2.5 A). FB clone Y and 12 were identified as 
carrying a single integration site by qPCR and microscopy (immunofluorescence [IF] or 
live cell imaging of GFP-enriched foci). These parental clones display the “default” 










Figure 2.5: The Tagged Chromosomal Insertion Site (TCIS System) allows for the site 
specific recombination of a DNA sequence of interest. (A) The TCIS system is 
composed of two previously described technologies: the lacO/LacI system (lac 
Operator / Lac repressor) and Recombination-Mediated Cassette Exchange (RMCE). 
This system allows us to tag a chromosomal region with lacO segments, recruit 
LacI fusion proteins and to site-specifically integrate specific single copy DNA 
sequences of interest by Cre-mediated recombination into inverted loxP sites. (Feng, 
1999; Robinett, 1996). Specifically, we integrated a linearized construct containing 
256 lacO repeats contiguous with two inverted loxP sites interrupted by thymidine kinase 
(TK) and hygromycin (Hyg) genes for negative and positive selection, respectively. TCIS 
cell lines were generated by introducing this linearized construct into 3T3 derived FB 
cells followed by positive selection with hygromycin. Individual isolated clones were 
screened by quantitative PCR (qPCR) for copy number and single sites of integration 
were verified by fluorescence microscopy of EGFP-LacI, which binds to and 
accumulates on the integrated lacO array, thus marking the insertion site.(B) 
Quantitation of IF versus FISH shows comparable positional determination of the TCIS 
system location (n ≥ 50). (C) TCIS insertion sites are centrally disposed and not in a 
lamina associated domain, as determined by DamID. QPCR to a region of the TCIS 
locus is not enriched in regions of the genome marked by Dam-LMNB1 when compared 
to Dam treatment alone. Primers to the Igh locus, a lamina associated regions in FB 
cells, is used as a positive control. Primers to a non-lamina associated regions (dip) are 
used as a negative control. The data shown are from a single representative experiment, 
out of three. (D) Efficient and successful ‘switching’ is tested by recombining in GFP 
coding gene into the TCIS region.  To determine the efficiency by which we can 
introduce new DNA sequences, we cloned a CMV-EGFP expression cassette into a 
vector containing inverted loxP sites that corresponded to the loxP sites in the TCIS 
integration (‘switch vector’) and FB cells were co-transfected with this construct along 
with a vector encoding Cre-recombinase into TCIS clone Y or clone 12.  Efficient 
switching takes place within 5d and is guaranteed by negative selection with 1µM 
gancyclovir for 24h (Feng, 1999). Flow cytometry shows a shift in GFP fluorescence in 
the whole population (green), compared to non-switched TCIS clones (purple). The data 






Figure 2.5: The Tagged Chromosomal Insertion Site (TCIS System) allows for the site 





(Figure 2.4, B and C; and Figure 2.5, B and C). We note that only a subset of the cells 
display EGFP-LacI foci detectable by 3D microscopy, as previously described (Belmont 
et al., 1999). Therefore, to ensure that we are able to measure disposition accurately 
using IF and EGFP-LacI foci as a readout, we demonstrated that 3D immuno-FISH to 
the lacO sequences reflected the same disposition as our IF strategy (Figure 2.5 B). 
Although we do not know the integration sites, the TCIS region is not associated with the 
nuclear lamina by DamID analyses, thus the default association is away from the nuclear 
lamina (Figure 2.5 C). Using this system, we are able to “switch” DNA segments into the 
TCIS system with high efficiency in as little as 5 d, with selection (Figure 2.5 D). Thus, 
the TCIS system enables testing of a single non-iterated LAS for its ability to target an 
ectopic genomic site to the nuclear periphery. Moreover, each LAS tested will be in the 
exact same genic location, thus mitigating misinterpretation of results based upon 
possible position effects caused by differential integration sites. 
The previously described Ikzf1 (A–O) fragments were therefore integrated into 
TCIS clone Y expressing EGFP-LacI to enable detection of disposition of the lacO sites 
(Figure 2.4, A–C, black bars). These potential LASs in single copy showed relatively the 
same probability of targeting to the nuclear periphery in FB cells as they did in multiple 
copy random integrations (Figure 2.6 C). The Ikzf1 (I) LAS (border) and a control from 
Igh LASs were tested in both of our clones Y and 12 (Figure 2.4, D and E; Zullo et al., 
2012); additionally, fragments from broader border regions near Bcl11a were integrated 
into clones 12 and Y, and similar results were obtained (Figure 2.3 E). The transitional 
Ikzf1 (I) LAS, which covers the outermost edge of the Ikzf1 LAD border region, was then 
further dissected to identify specific DNA elements with roles in establishing and/or 
defining a LAD. Specifically, 2.5-kbp subfragments covering the entire Ikzf1 (I) were 
switched into clone Y. The smaller Ikzf1 (I) LAS fragments comprised of sequences 




















Figure 2.6: YY1 binding sites are enriched in LAS. (A) Profiles of aligned LAD border 
regions (Chr 9-14; left and mirrored right border regions combined) are shown for Lamin 
B1 binding, YY1 and CTCF binding site density and H3K27me3. To align LAD borders, 
genome-wide positions of all analyzed features were converted to coordinates relative to 
the nearest border. Grey area and positive coordinates, inside LADs; white area and 
negative coordinates, outside LADs. (B) DamID histograms in FB (blue), ESC cells 
(green, Peric-Hupkes, 2010, GSE17051) and proB cells, orange. Histograms are 
log2(Dam-LMNB1/Dam) and positive signal indicates a LAD region. The solid blue and 
orange bars underscore LADs. The Ikzf1 locus (blue) and BAC used to generate the 
smaller fragments (green), is shown below the fragments. LAS are red and non-
repositioning fragments are gray. (C) Depicts magnification of the Ikzf1 LAD border (light 
yellow from panel C). Sub-fragments (1-9) of the Ikzf1(I) LAS are shown relative to ChIP-
Seq data from ESC and proB cells show YY1 binding site enrichment (YY1, 











repositioning (Figure 2.7). We note that Ikzf1 (I) LAS fragments 3 and 4 straddle the 
defined border region. These results indicate that there is both a sharp edge delimiting 
lamin-associated regions and that sufficient information required for repositioning to the 
nuclear periphery resides at or inside LAD boundaries in small LASs (<2.5 kbp). 
 
2.3.4: Cell type–specific transcription factors and proteins involved in nuclear 
architecture and scaffolding are involved in sequence targeting 
We next aimed to determine enrichment of protein binding motifs within Ikzf1 (A–
E and G–I) LAS that would serve to identify potential protein candidates for further 
functional analyses. An initial search using MEME and TomTom identified YY1 (Ying- 
Yang 1), CTCF, and cKrox/ThPOk/Zbtb7b (as well as other BTB/POZ domain 
proteins)binding site motifs as among those enriched in these sequences (see Materials 
and methods; Figure 2.8, A and B). Not surprisingly, we also identified several binding 
sites for specific B cell development proteins (not depicted). Both CTCF and Zbtb7b 
binding site motifs were previously identified in LADs/LAS (Guelen et al., 2008; Zullo et 
al., 2012). Intriguingly, YY1 is known to have roles in genome regulation in many cell 
types, including both gene activation and repression, and has been implicated to recruit 
polycomb repressive complex 2 (PRC2) to chromatin to enable H3K27me3 (Satijn et al., 
2001; Atchison et al., 2003; Caretti et al., 2004; Srinivasan and Atchison, 2004; Liu et al., 
2007; O’Meara and Simon, 2012; Pan et al., 2013; Atchison, 2014).  
We next undertook to identify all potential YY1 binding sites in LAD border 
regions via pair-weighted matrix motif analyses. Specifically, we analyzed the disposition 
of predicted YY1 and CTCF binding sites (Figure 2.8, A and B) over chromosomes 11 
and 12 using MEME Suite and Genometricorr (Claeys et al., 2012; Favorov et al., 2012). 
Using the MEME-identified motifs, we generated maps of sites along each fragment 



















Figure 2.7: Minimal vLAD border sequences target to the nuclear periphery. (A) The 
lamina-targeting Ikzf1 fragment I was further segmented (fragments 1-9) and ‘switched’ 
into TCIS clone Y. (B) Quantitation of peripheral association was determined by overlap 
of EGFP-LacI focus and anti-LMNB1 signal (n ≥ 50). NS is non-switched; I and O are the 
larger fragments (n ≥ 50). Error bars are the SD of imaging data as scored by two 







Figure 2.8: YY1, BTB/POZ type proteins and CTCF potential binding sites are enriched 
in LAS and at vLAD borders (A) Motif Suite analysis of LAS reveal binding motifs for 
YY1, BTB/POZ binding domain proteins and CTCF. The occurrence and distribution of 
the identified motifs (horizontal ticks) are indicated along the fragments. (B) Fold-
enrichment of identified motifs in fragments (A-O, I) relative to random regions of 
chromosome 11 away from LAD borders from either MEME generated motifs or from the 
transcription factor binding motif databases Factorbook and JASPAR. For comparison, 
motifs on known YY1 responsive elements surrounding the Surf1/2 gene and the Emµ 
enhancer from the IgH locus size-matched to fragment I, are shown. (C) DamID 
determined traces in FB (blue) and Rag-/- proB cells (orange). FB and proB LADs are 
indicated by solid blue and orange bars, respectively. Ikzf1 locus (blue) is below the 
LADs. Peripherally targeting fragments (A-I, red) from the vLAD containing Ikzf1 and 
non- targeting fragment O are in gray. CTCF ChIP-Seq data, green (show peaks at the 
border of the FB specific vLAD in MEFs and Rag-/- proB cells [Robertson, 2007 (GEO: 





using the MAST algorithm (Figure 2.8 A). In addition, because the output of MEME 
simply indicates a statistically significant enrichment of a given motif, we next analyzed 
the fold enrichment of identified motifs in our fragments relative to random regions of 
chromosome 11 away from LAD borders from either MEME generated motifs or from the 
transcription factor binding motif databases Factorbook and JASPAR (Figure 2.8 B; 
Sandelin et al., 2004; Wang et al., 2012; Mathelier et al., 2014). For comparison, we 
show enrichment of these MEME and Factorbook motifs on known YY1 responsive 
elements surrounding the Surf1/2 gene (Surfeit locus protein 1 and 2) and the Emu 
enhancer from the Igh locus size matched to fragment I, for comparison (Figure 2.8 B; 
Cole and Gaston, 1997). Using MotifSuite, we estimate an approximately twofold 
enrichment of YY1 binding sites at LAD borders (±10 kb) relative to chromosomal 
background (unpublished data; Claeys et al., 2012). Finally, the statistical correlation 
package Genometricorr indicates that YY1 binding sites, either derived from our MEME 
analyses or from the Factorbook database of binding motifs, are more enriched relative 
to LAD borders compared with what would be expected by random chance (P < 0.001; 
Favorov et al., 2012). 
These initial lead candidate analyses led us to next identify actual YY1 
occupancy relative to LADs. Leveraging publicly available data of YY1 binding and 
LMNB1-DamID (e.g., LAD) maps in embryonic stem cells (ESCs) along with our data 
and publicly available data in proB cells, we found that high peaks of YY1 binding often 
correlated with LAD boundaries (Figure 2.6 A; Mendenhall et al., 2010; Peric-Hupkes et 
al., 2010; Vella et al., 2012). We note that in the Ikzf1, Bcl11a, and Igh loci, the LAD 
configuration in ESCs mimics those seen in FB (Figure 2.6 B, top). In addition, we note 
that the smaller relocating fragments (fragments 1–4), some of which, by bioinformatics 
analyses, were not identified as enriched in YY1 binding sites, nonetheless display YY1 




is thus very important to note the obvious: there are a large number of regions actually 
occupied by YY1 both inside and, more predominantly, outside of LAD border regions 
and, in the case of previously published results in ESC cells, YY1 occupancy is often 
associated with active promoter regions (Figure 2.6 A; Vella et al., 2012). Interestingly, 
although Ikzf1 is in a LAD in ESCs, it is not in proB cells, yet in both cell types, these 
regions have demonstrated YY1 binding (Figure 2.6 C). This likely reflects both the 
diversity of YY1 functions and its potential dual roles in regulating these regions. We 
also note, as has been previously reported, that we find CTCF binding motifs to be 
enriched at LAD borders (Figures 2.6 A and 2.8, A and B; Guelen et al., 2008). In all 
cases, the putative and determined binding sites were shown to be enriched in LAD 
border regions; however, it is quite evident that these regions are far from the only 
regions bound by these factors. Given these and previous data, we suspected that 
targeting to the lamina may depend upon on a combination of cell type–specific factors 
(such as BTB-POZ domain proteins; Figure 2.8, A and B) as well as epigenome/genome 
organizers, such as YY1, PRC2 components (e.g., EZH2), lamins, and/or CTCF (Figure 
2.8 C). However, it was also clear from these analyses that simply trying to determine 
bioinformatically (motif or occupancy analyses) the roles of these proteins in LAD 
establishment would be problematic.   
To more rigorously determine the role of the identified candidate proteins in LAD 
establishment and/or maintenance, we used a targeted shRNA-mediated knockdown 
strategy (Figure 2.9). Specifically, a test fragment from the Ikzf1 vLAD border (LAS I) 
and a control fragment from the Igh vLAD (LAS N) were introduced into TCIS insertion 
sites in clone 12 and Y, and these same cells were then subjected to shRNA-mediated 
knockdown of either proteins previously identified to be important for de novo lamina 






Figure 2.9: Knockdown of Zbtb7b, CTCF, YY1, EZH2 or LMNA/C leads to a loss of 
peripheral association of LAS. (A) Immunoblot analysis of protein lysates from TCIS 
lines Y and 12, harboring LAS Ikzf1 (I) or Igh (N) and control ‘non-switched’ (NS) with 
either off-target or target shRNA as indicated to the left of each blot. (B, C) Quantitation 
of IF testing the disposition of lacO and LMNB1 in TCIS clones harboring the (B) Ikzf1(I) 
or (C) Igh (N) LAS, after 4d treatment with indicated shRNA (n≥50, P≤ 0.001). (D) 
Quantitation of 3D DNA ImmunoFISH for BAC probes to the indicated endogenous LAD 





literature (LMNA/C) or in this study (CTCF, YY1, and the PRC2 component EZH2). We 
determined the disposition of the LAS before shRNA-mediated knockdown with either an 
off-target shRNA control or with the indicated protein target (Figure 2.9). Lap2-β and 
HDAC3 shRNA mediated knockdowns led to substantial cellular death and were, 
therefore, not able to be analyzed with confidence; however, the remainder of the 
constructs appeared to have little effect on cell viability within the time frame used by our 
assays (Figure 2.10). Interestingly, all of these knockdowns, with the prominent 
exception of LMNA, led to the loss of peripheral association of targeting fragments 
(Figure 2.9, B and C, P < 0.05). It is important to note that the LMNA knockdown 
construct specifically knocks down LMNA, whereas the LMNA/C construct knocks down 
both LMNA and LMNC (Figure 2.9, B and C). Given these results, it is tempting to 
speculate that LMNC, but not LMNA, is important for maintaining lamina-proximal 
positioning. We next asked whether the proteins demonstrated to impact LAS-directed 
targeting to the nuclear lamina also affected endogenous LAD organization. Both 
LMNA/C and YY1 perturbation reduced the association of endogenous LADs containing 
Ikzf1, Igh, and Bcl11a with the nuclear lamina as determined by 3D immuno-FISH 
(Figure 2.9 D, P < 0.005). In contrast, disruption of Zbtb7b only affected the association 
of the Igh locus with the lamina with any degree of statistical significance (Figure 2.9 D). 
Collectively, these data suggest that peripheral targeting and maintenance of lamina 
association of these regions is dependent on both LMNA/C and YY1. Again, ablation of 
LMNA alone had no effect on the disposition of endogenous loci.  Because YY1 shRNA-
mediated knockdown affected the nuclear disposition of both ectopically recruited TCIS 
sites and endogenous loci (Figure 2.9), we specifically tested whether YY1 is sufficient 
to target an ectopic site to the nuclear periphery. To enable such an experimental test, 
we expressed a YY1-EGFP-LacI fusion protein in our clones Y and 12 (harboring the 



















Figure 2.10: Cell survival after 4 days of shRNA treatment (A) Cell survival, as 
expressed by cell counts of treated cells over non-transduced (NT) after 4 day treatment 





allowing for regulated accumulation of YY1 at the integration site (Figure 2.11, C and D). 
The YY1-EGFP-LacI fusion protein displayed the same punctate distribution in the 
nucleus as endogenous YY1, making identification of the bound lacO array difficult in 
most cells (Figure 2.12 A). We note, however, that some cells express the fusion at 
lower levels and were thus able to be assayed by IF; in these cells, the YY1-EGFP-LacI 
loci collocate with YY1-enriched foci (Figure 2.12 B). To enable clear identification of the 
disposition of these YY1-bound TCIS insertions, we performed 3D immuno-FISH and 
measured their association with thee nuclear periphery using LMNB1 to demarcate the 
nuclear periphery (Figure 2.11, C and D). Although these integrations are centrally 
disposed when bound by EGFP-LacI, nearly 80% of the YY1-EGFP-LacI foci are at the 
nuclear periphery after 24 h. This finding is also borne out by DamID analyses of YY1-
bound TCIS loci (Figure 2.11 E, Ikzf1 (I) or -IPTG, black bars) compared with controls 
(Figure 2.11 E, nonswitched and +IPTG, black bars). We note that LAS I switched into 
TCIS also displays lamina association by DamID (Figure 2.11 E). In these experiments, 
relative lamina association and efficacy of the DamID protocol was monitored in the 
same experiment by PCR using Igh primers internal to the Igh vLAD. Specificity of the 
protocol was measured by using primers to detect a region in a small “dip” between and 
proximal to LAD regions (Figure 2.11 E; Wen et al., 2012). Importantly, simply 
overexpressing YY1 does not lead to repositioning of ectopic TCIS integrations (without 
recruitment to the lacO array, ±IPTG) or the control (dip) region to the lamina, indicating 
that simply overexpressing YY1 does not cause global reorganization to the nuclear 
lamina or even spreading into LAD proximal regions (dip; Figure 2.11). An accumulation 
of the YY1 protein, at a discrete site, is therefore sufficient to target to the nuclear 
periphery. In contrast, tethering of Zbtb7b is not sufficient to drive these regions to the 















Figure 2.11: YY1 targets chromatin to the nuclear periphery. (A) Expression of YY1 and 
Zbtb7b fusions to EGFP-LacI were verified by immunoblot by detecting with α-GFP (B) 
qRT-PCR of Col1A1 and fibronectin in FB cells overexpressing Zbtb7b-EGFP-LacI. (C) 
Representative images of 3D DNA-ImmunoFISH. EGFP-LacI, YY1-EGFP-LacI or 
Zbtb7b-EGFP-LacI fusion proteins detected by α-LacI (magenta, arrowhead) co-localize 
with the TCIS insert site (lacO probe, green, arrowhead) and LMNB1 (red). (D) 
Quantitation of 3D DNA ImmunoFISH for lacO/LacI position in two TCIS clones [n ≥ 50, 
(p≤0.001)]. (E) qPCR analysis of Dam-LMNB1/Dam in clone Y and 12 under the 
indicated conditions. A value >1 for [Dam-LMNB1/ Dam only] indicates enrichment.  
Primers to the TCIS locus, the Igh locus (+ control) and a non-lamina associated region, 
dip (- control), were used for amplification. The data shown are from a single 
representative experiment.  (F) Representative images of 3D DNA-ImmunoFISH in clone 
Y containing either Ikzf1 (I) LAS or YY1-EGFP-LacI (+/- IPTG). LMNB1 (red), γ-satellite 
(cyan), lacO probe (green) and Hoechst (blue). (G) Quantitation of 3D DNA 
ImmunoFISH for lacO position in relationship to both the nuclear lamina and γ-satellite 
DNA with either Ikzf1(I) LAS integrated or YY1 bound (n ≥ 50, p≤0.001). (H) Quantitation 
of the disposition of lacO sites by 3D ImmunoFISH analysis in clone 12 and Y 
overexpressing YY1-EGFP-LacI(-IPTG) before and after shRNA mediated knockdown 































Figure 2.12: Endogenous and overexpressed YY1 in fibroblasts (A) IF using α-YY1 in 
either wild-type or YY1-EGFP-LacI expressing FB (green). YY1 is punctate in cells and 
does not co-localize to H3K27me3 signal (red). Inset is 300X magnification.  (B) YY1-
EGFP-LacI, when expressed in a FB TCIS clone, leads to de novo LAD formation. 
LMNB1 (red), YY1-EGFP-LacI (green), Hoechst (blue) and YY1 (magenta). Arrowhead 






appears to be functional, as assayed by reduction in col1a1 (collagen, type I, α 1) and 
fibronectin gene expression (Figure 2.11, A–D; Widom et al., 1997; Renard et al., 2008). 
Interestingly, YY1 is not normally enriched at the nuclear lamina, although we do detect 
faint rim staining upon longer exposure when detecting endogenous YY1 by IF (Figure 
2.13). However, we note that although YY1 is not obviously enriched at the nuclear 
lamina in most cells, H3K27me3 and Hoechst-stained heterochromatin is indeed 
enriched in the region underlying the lamina, enhanced in those cells overexpressing 
YY1 (Figure 2.12 A, B).  
Interestingly, there are previous studies indicating that recruitment of YY1 leads 
to association with pericentromeric heterochromatin (Shestakova et al., 2004; Josse et 
al., 2012). We therefore asked whether directed recruitment of YY1 led to the assays to 
determine the amount of colocalization of the YY1- bound TCIS locus with association of 
the TCIS site with these domains by using either 3D immuno-FISH or IF either 
pericentromeric γ -satellite DNA or with the centromeric protein CENP-A (Figure 2.11, F 
and G; and Figure 2.14, A and B). We observe no increase in association with either of 
these subnuclear regions. Collectively, these data indicate that YY1 is able to direct 
recruitment of an ectopic site to the nuclear lamina and that this recruitment is 
independent of association with pericentromeric or centromeric heterochromatin 
domains. Given that YY1 recruitment to TCIS is sufficient to target that region of the 
genome to the nuclear lamina, we next asked whether such repositioning was 
dependent on putative YY1 interactors and/ or lamina proteins. Both CTCF and BTB-
POZ proteins have been implicated to interact with YY1 (Donohoe et al., 2007; 
Zlatanova and Caiafa, 2009; Boulay et al., 2012). shRNA-mediated knockdown of 
LMNA/C was able to prevent or disrupt YY1-mediated tethering to the nuclear lamina, 
although LMNA knockdown alone was not sufficient to cause disruption of this 


















Figure 2.13: Endogenous YY1 shows a faint rim stain at the nuclear periphery. 
Endogenous expression of YY1 (yellow) in TCIS clone Y expressing EGFP-LacI (green), 










Figure 2.14: Fragment or YY1 driven de novo LADs do not associate with centromeric 
heterochromatin. (A) Representative images of 3D DNA-ImmunoFISH in TCIS clones 
containing either a switched fragment I, or harboring YY1-EGFP-LacI in the presence 
and absence of IPTG. Lamin B (red), EGFP-LacI (green), CENP-A (magenta) and 
Hoechst (blue). (B) Quantitation of Immunofluoresnce for EGFP-LacI association with 





disrupt peripheral association, indicating either that these proteins are not involved in 
this process or that YY1 recruitment is able to bypass their functional requirements 
(Figure 2.11 H). Nonetheless, these data show that YY1-mediated recruitment to the 
nuclear lamina depends on LMNC and, possibly, LMNA/C levels. 
Intriguingly, H3K27me3 has been reported to be enriched at LAD borders but not 
LAD interiors (Guelen et al., 2008). Using publicly available data identifying H3K27me3 
in MEFs (GEO accession no. GSE48649), we also note that there is a striking 
enrichment of H3K27me3 at the border of the LADs containing the Ikzf1, Igh, and Bcl11 
a loci and more generally at LAD borders (Figure 2.15, A and B; and Figure 2.6 A; 
Simon et al., 2013). These H3K27me3 modifications overlap with our relocating 
fragments (Figure 2.15 C). We next asked whether YY1 recruitment to the TCIS locus 
mirrored what is observed at endogenous LAD borders, namely the accumulation of 
H3K27me3-modified chromatin at the insert site (Figure 2.15, B and C). By chromatin 
immunoprecipitation (ChIP), we detected strong enrichment of H3K27me3 upon 
recruitment of YY1 and found, additionally, that our inserts harbor H3K9me2/3 
modifications independent of YY1 recruitment (Figure 2.15 D). We note that the 
antibodies used for detecting the H3K9 methyl modifications have significant cross-
reactivity between dimethyl and trimethyl variants, and so, we describe our data in terms 
of H3K9me2/3 (Peach et al., 2012). Intriguingly, a recent study indicated that H3K9 
methyl status may determine chromosomal positioning at the lamina of ectopic insertion 
sites (Bian et al., 2013). In addition, genome-wide analyses in C. elegans have shown a 
correlation between H3K9me1/2/3 enrichment and LAD regions (Towbin et al., 2012). 
Moreover, H3K9me2 has been previously reported to play a role in LAD organization 















Figure 2.15: H3K27me3 enriched at endogenous LAD borders and YY1-bound TCIS. 
(A, B) H3K27me3 enrichment at LAD borders (Simon, 2013, GSE48649).  The entire FB 
LAD is shown for Ikzf1 and Igh to enable visualization of both borders and blue bar 
underscores LAD region determined by LAD histograms [log2(Dam-LMNB1/Dam)]. The 
genes are shown (blue) and the Ikzf1 vLAD border region tested in this study is 
highlighted in yellow. Primers used for ChIP to the Igh locus are indicated (orange). (C) 
Magnification of the 20kb edge of the FB specific vLAD containing Ikzf1. LAS (magenta) 
and non-targeting fragments (gray) are shown above H3K27me3 histograms. (D) ChIP 
analysis of YY1-recrutied to the TCIS locus (+/- IPTG). Enrichment of H3K9me2, 










in the interior of the LAD comprising the Igh locus (Figure 2.15 D; Johnson et al., 2004). 
As expected, these more interior primers of the Igh LAD did not detect an enrichment of 
H3K27me3, indicating that this modification is present at border regions of LADs, but not 
the interior, in agreement with our and others’ analyses of H3K27me3 ChIP-seq 
signatures relative to LAD borders (Figures 2.6 A and 2.15 D; Guelen et al., 2008). We 
therefore conclude that our YY1-bound TCIS system likely recapitulates the endogenous 
chromatin state of LAD borders in that they have both H3K9me2/3 and H3K27me3 
modifications. 
YY1 has been shown to act as both a negative and positive transcriptional 
regulator (Thomas and Seto, 1999); however, one reported role is in recruiting PRC2 to 
mediate transcriptional repression (Basu and Atchison, 2010; O’Meara and Simon, 2012; 
Basu et al., 2014). Previously, we showed that reduction in the PRC2 histone 
methyltransferase component EZH2, which trimethylates histone H3 on lysine 27, led to 
the loss of peripheral association of a LAS fragment (Figure 2.9). In addition, disruption 
of EZH2 prevented YY1-mediated recruitment to the nuclear lamina, indicating that 
H3K27me3 is necessary for this repositioning as well (Figure 2.11 H). We note, 
however, that overexpression of YY1 concomitant with disruption of EZH2 in the same 
cells led to a substantial decrease in cell viability (unpublished data). As a separate test 
to determine whether H3K27me3 was required for the YY1-mediated repositioning, we 
treated TCIS clones with either relocating LAS fragments recombined into the locus 
(Figure 2.9) or bound by YY1 (Figure 2.11) with 3-deazaneplanocin (DZNep). DZNep is 
an indirect inhibitor of S-adenosyl-methionine–dependent methylation that disrupts EZH2 
function, thus blocking H3K27me3 deposition. In addition, there are reports that, 
depending on the study, implicate DZNep in the reduction of H3K4me3, H4K20me3, and 
at higher concentrations, H3K9me3 (Figure 2.16 A; Fiskus et al., 2009; Miranda et al., 




Figure 2.16: DZNep treatment leads to loss of peripheral targeting. (A) Immunoblot 
analysis of H3K27me3 in clones 12 and Y +/- 5µM DZNep treatment for 24h. (B) 
Representative images of clone Y harboring the Ikzf1 (4) LAS, +/- DZNep treatment. 
EGFP-LacI foci (green, arrowhead) are shown relative to LMNB1 (red) and H3K27me3 
(magenta). (C) Quantitation of IF for DZNep treatment of clone Y harboring Igh (N) and 
Ikzf1 (4) LAS and a non-targeting fragment Ikzf1 (8), n ≥ 50, p≤0.05. (D) Quantitation of 
IF of 24h, 5µM DZNep treated clones Y and 12 expressing EGFP-LacI or YY1-EGFP-
LacI, n ≥ 50, P≤0.001. Error bars are SD. (E) Quantitation of 3D DNA ImmunoFISH for 





of the EZH2 methyltransferase because loss of EZH2 might lead to destabilization of 
some of the YY1 containing complexes, thus making results from such an experiment 
difficult to interpret. We note that treatment with 5 μM DZNep resulted in modest effects 
on cell proliferation at 24 h of treatment (the time point used for our assays), but the cells 
appeared to be otherwise healthy (Figure 2.17). Strikingly, lamina association driven by 
LASs are disrupted when treated with DZNep (Figure 2.16, B and C) as they are with 
EZH2 knockdown (Figure 2.9, B and C), indicating that their repositioning is dependent 
on H3K27me3. Intriguingly, DZNep treatment affected all LAS fragments similarly, 
including the Igh(N) LAS, indicating that either H3K27me3 is involved in initiating lamina 
association regardless of LAS origin or that our treatments also affected other histone 
modifications necessary for repositioning, especially H3K9me2/3 (see following 
paragraph; Figure 2.16 C; Towbin et al., 2012; Bian et al., 2013). However, in support of 
a strong role for H3K27me3 in LAS-directed repositioning, shRNA-mediated knockdown 
gave similar results for these same LAS fragments (Figure 2.9 C). Similarly, DZNep 
treatment of either YY1-bound loci or endogenous LADs resulted in their movement 
away from the nuclear lamina, again similar to our findings with shRNA-mediated 
knockdown of EZH2 (Figure 2.16, D and E). Collectively, these results suggest that 
H3K27me3 is necessary to target to and maintain proximity to the nuclear lamina. As 
previously mentioned, there are studies in the literature implicating histone H3K9me2/3 
modifications in recruitment of domains to the nuclear lamina. We also note that our 
TCIS system harbors H3K9me2/3-modified chromatin, as has been previously reported 















Figure 2.17: Cell survival with Bix-01294 treatment. Cell survival, as expressed by cell 
counts of treated cells over non-transduced (NT) after 24 hour treatment of DMSO 






Taking these findings into consideration, we next asked whether the association 
with the nuclear lamina might be dependent on both types of modifications—a potential 
bivalent heterochromatin signal. Intriguingly, H3K9me2/3 modifications appear to be 
broadly distributed across LAD domains (unpublished data; Towbin et al., 2012), 
although H3K27me3 modifications appear to be restricted (relative to LADs) at the 
border regions (Figure 2.15; Guelen et al., 2008). These border regions may represent 
regions where the genome is constantly reestablishing LAD boundaries as indicated by 
the preponderance of active promoters immediately flanking LADs (Guelen et al., 2008). 
To test whether repositioning of ectopic regions to the nuclear lamina requires 
H3K9me2/3 modifications, we used the inhibitor BIX-01924 to block histone 
dimethylation at lysine 9 of H3 (Kubicek et al., 2007; Bian et al., 2013). We chose to use 
this inhibitor because, despite our best efforts, we were unable to find an shRNA 
construct for G9a (the methyltransferase responsible for H3K9me2; Lachner and 
Jenuwein, 2002) that worked without significant cell death (unpublished data). Western 
blots show that treatment with 5 μM BIX-01924 leads specifically to inhibition of 
H3K9me2 but not H3K9me3 (Figure 2.18, A and B). Initially, we subjected cells 
harboring our TCIS system with the Ikzf1 (I) LAS or with YY1 bound to treatment with the 
inhibitor for 24 h, and, although we saw significant down-regulation of H3K9me2, we 
were unable to reliably detect loss of lamina association (Figure 2.18, C and D). 
Interestingly, another study also tried using BIX-01924 to disrupt lamina associations 
through down-regulation of H3K9me2 but also were unable to detect loss of association; 
however, the authors noted that their assays to detect lamina association were designed 
to detect within 0.5 μm of the nuclear lamina, and therefore, they may have missed a 














Figure 2.18: H3K9me2/3 is necessary for de novo LAD formation. (A, B) Immunoblot 
analysis of protein lysates from TCIS lines either harboring Ikzf1 (I) LAS or bound by 
YY1-EGFP-LacI (-IPTG) and control, ‘non-switched’.  Cells were treated with either 
vehicle (DMSO) or 5µM Bix-01294 for 24 or 60h.  Proteins were detected by the 
antibodies indicated; loading control is total histone H3. (C) Representative images of 
clone Y harboring the Ikzf1 (I) LAS +/-5µM Bix-01294 after 24 or 60h treatment. EGFP-
LacI foci (arrowhead), LMNB1 (red) and Hoechst (blue). Insets, 300X. (D) Quantitation of 
the disposition of the TCIS insert  for vehicle and 5µM Bix-01294 treatment at 24 and 
60h treatment of clone Y harboring Ikzf1(I) LAS and YY1-EGFP-LacI (-IPTG, n ≥ 50).  
(E) qPCR analysis of DamID in clone Y harboring Ikzf1(I) LAS, +/- 5µM Bix-01294 (60h). 
A value >1 of, Dam-LMNB1 over Dam only, indicates enrichment of the tested locus.  
Positive and negative controls are primers to an internal region of the Igh locus and a 
non-lamina associated region, dip, as previously. The data shown are from a single 
representative experiment. (F) Quantitation of 3D DNA ImmunoFISH for the indicated in 
48h, 5µM Bix-01294 treated MEFs (n ≥ 50, p≤0.01). (G)  Immunoblot analysis of protein 
lysates from TCIS clone Y harboring Ikzf1 (I) LAS or YY1-EGFP-LacI (-IPTG) treated 
with indicated shRNAs. Proteins were detected by the antibodies indicated; loading 
control is total histone H3. (H) Quantitation of the disposition of TCIS sites of clone Y 
harboring Ikzf1 (I) LAS or bound by YY1-EGFP-LacI treated shRNAs as indicated (48h, 









 modification with recruitment to the lamina (Towbin et al., 2012). We noted a slight, but 
not statistically significant, loss of association of our targeting fragments but were struck 
by a qualitative difference in the lamina association. 
Because of these conflicting studies in the literature and our somewhat 
ambiguous cytological data, we decided to repeat this experiment to enable both 
cytological and DamID analyses. Specifically, we treated cells harboring relocated TCIS 
sites with BIX-01294 for 12 h and then transduced these cells with Dam or Dam-LMNB1 
and harvested after 48 h (total of 60 h). We noted some slowdown of cell division at this 
time point, but the cells were healthy and still undergoing division (unpublished data; 
Kubicek et al., 2007). At this time point, there is statistically significant repositioning 
away from the nuclear lamina, but at a relatively low frequency (Figure 2.18 D). 
However, by using DamID to measure lamina association, there was, quit strikingly, a 
complete loss of association with the nuclear lamina (Figure 2.18 E). We tested whether 
BIX-01294 treatment affected endogenous loci as well and chose to use an intermediate 
time point (48 h). The endogenous loci, in contrast to our TCIS relocated fragments, 
show appreciable loss of association (Figure 3.18 F). We next queried whether 
H3K9me3 affected our loci in the same way by using an shRNA-mediated knockdown of 
the SUV39H1 (Suppressor of Variegation 3–9 homologue 1), a methyltransferase that 
mediates H3K9me3 (Figure 2.18, G and H; Lachner and Jenuwein, 2002). Although 
SUV39H1 knockdown did disrupt localization of both the LAS- and YY1-directed lamina 
association, we were unable to attribute this directly to H3K9me3 because removal of 
SUV39H1 also perturbed H3K9me2 levels (Figure 2.18 G). Although we found this result 
somewhat surprising, we note that loss of SUV39H1 has previously been shown to 
disrupt H3K9me2 (Murayama et al., 2008). Nonetheless, these data provide compelling 
evidence that both H3K27me3 and H3K9me2/3 are required for targeting an ectopic site 





Our results implicate specific DNA sequences within LADs and chromatin state, 
specifically H3K27me3 and H3K9me2/3, in establishing de novo lamina associations. In 
addition, we suggest a role for levels of A-type lamins and, specifically, LMNC in 
regulating this repositioning (Figure  2.19). Our work focused on LAD border regions. We 
show that some LASs are sufficient for directing an ectopic site to the nuclear lamina, 
and this repositioning is dependent on YY1 (Figure 2.9) and H3K27me3 (Figures 2.9 and 
2.16), a histone modification demonstrated to be enriched in these regions at 
endogenous LADs (Figures 2.16 and 2.6 A; Shah et al., 2013). We demonstrate, in 
agreement with two previous studies, that directed association with the nuclear lamina is 
also dependent on H3K9me2/3 (Figures 2.18; Towbin et al., 2012; Bian et al., 2013). In 
addition, a recent study, using a human fibrosarcoma cancer cell line (HTC75), 
demonstrated that using either BIX-01294 or G9a shRNA-mediated knockdown to 
perturb H3K9me2 resulted in loss of LAD association with the nuclear periphery (Kind et 
al., 2013). Recent work in our laboratory also shows that these modifications are 
necessary for functional organization of a chromosomal territory (unpublished data). 
Thus, we speculate that these LAD border regions, which are enriched in both 
H3K27me3 and H3K9me2/3, constitute a targeting signal for LAD formation (Figure 
2.19). Intriguingly, recent studies have also identified specific nuclear envelope 
transmembrane proteins as involved in organizing and regulating chromatin at the 




Figure 2.19: A model for directed reorganization of chromatin. A cross-section of a 
portion of the interior of a FB nucleus shows chromatin as a lamina associated domain 
(LAD, red with yellow borders) or a non-lamina associated region (green). An ectopic 
insertion of a LAS into the TCIS insert site is poised for relocation to the lamina due to 
H3K9me2/3 modifications present on the insert (red). Acquisition of H3K27me3 (yellow) 
leads to lamina association. Abrogation of H3K27me3 by knock-down of EZH2 or 
specific transcriptional repressors or by drug inhibition, leads to loss of peripheral 
targeting at both endogenous and ectopic loci.  Our data suggests that K27me3 
precedes movement to the lamina. Abrogation of H3K9me2/3 leads to a loss of 
association of endogenous and ectopic loci, as has also been shown by previous studies 
(Bian, 2013, Towbin, 2013, Kind 2013). We propose that these two facultative 
heterochromatin marks, H3k27me3 and H3k9me2/3, cooperate (bi-valency) to drive LAD 
formation and/or maintenance. Intriguingly, we also uncovered a potential role for LMNC 
(or LMNA/C levels) in this process and disruptions in LMNA/C have been linked to global 




therefore propose a model for regulation of vLADs that incorporates cell type–specific 
transcription factors, chromatin modifiers and organizers, and nuclear lamina proteins to 
facilitate cell type–specific genome organization (Figure 2.19). The work described 
herein focused on functional tests of LAD organization at LAD borders. In agreement 
with a previous study, we find that GA-rich sequence motifs, potentially bound by BTB-
POZ domain proteins, are overrepresented in lamina relocating fragments but also find 
an enrichment of YY1 and CTCF binding sites (Figures 2.6 B, 2.7 and 2.8). The 
presence of CTCF binding sites was not unexpected as a result of its known enrichment 
at the boundaries of LADs (Vogel et al., 2007; Guelen et al., 2008; Handoko et al., 
2011). As a previous study has indicated that robust YY1 binding often requires a 
cofactor (Golebiowski et al., 2012), we speculate that Zbtb7b or another transcription 
factor (or even CTCF) may be required to recruit or enhance YY1 or PRC2 binding in 
vLAD border sequences to facilitate repositioning to the lamina. In support of this, a 
recent study has implicated BTB-POZ domain proteins in the recruitment of PRC2 to 
chromatin, possibly through interactions with YY1 (Boulay et al., 2012). Intriguingly, in 
Drosophila melanogaster neurons, competition by BTB-POZ–related proteins for GAGA 
sites determines the disposition and transcription state of the neural competence factor 
Hunchback (Lehmann et al., 1998; Kohwi et al., 2013). It is therefore tempting to 
speculate that specific cell type–specific transcription factors can promote or inhibit 
association with the nuclear lamina through their interactions with chromatin remodelers 
for the induction of large scale chromatin changes concurrent with either localization to 
or away from the nuclear periphery. This latter point is important because transcriptional 
activation appears to disrupt associations with the nuclear lamina (Tumbar et al., 1999; 
Tumbar and Belmont, 2001; Bubulya and Spector, 2004). Both Zbtb7b and YY1 have 
been shown to repress and activate genes, adding to the potential for cell type–specific 




There are studies in the literature indicating that YY1 may interact with and 
enhance the activity of HDAC3, thus potentially linking cell type–specific regulation 
through factors such as Zbtb7b, with a more general model implicating 
epigenome/genome organizers and specific structural proteins (e.g., LMNA/C and Lap2- 
β) at the nuclear periphery in positioning chromatin to the nuclear lamina (Figure 2.19; 
Somech et al., 2005; Sankar et al., 2008; Faulk and Kim, 2009; Atchison, 2014; 
Luperchio et al., 2014). Interestingly, CTCF has been proposed to interact with YY1 to 
mediate cell type–specific organization, raising the possibility that CTCF and YY1 act 
together to target and delimit LAD boundaries (Phillips-Cremins et al., 2013). Numerous 
studies have implicated the interaction of these two proteins in both nuclear architecture 
and in gene regulation (Donohoe et al., 2007; Kim, 2008; Nikolaev et al., 2009; Degner 
et al., 2011; Weth and Renkawitz, 2011; Medvedovic et al., 2013; Wei et al., 2013). 
Finally, our results also suggest that LMNA/C is important in instructing the peripheral 
localization of these sequences (Figure 2.9). Two recent studies have implicated LMNA 
in large scale chromatin organization, but these data did not differentiate between LMNA 
and LMNC (McCord et al., 2013; Solovei et al., 2013). Our data suggest that either 
overall levels of LMNA/C are important or, more intriguingly, that LMNC is required for 
proper genome organization. What is clear from our results is that LMNA is not 
necessary for recruitment or retention at the nuclear lamina. This suggests, contrary to 
the commonly held position that there is functional redundancy between LMNA and C, 
that LMNC may be specifically involved in instructing peripheral positioning. Consistent 
with this, are studies that “LMNC-only” mice (missing LMNA but with normal LMNC 
levels) are viable, yet LMNA/C+/- have perturbed differentiation (Fong et al., 2006; Sehgal 
et al., 2013). Intriguingly, we detect both H3K27me3 and YY1 at the nuclear lamina, 




speculate that YY1 and PRC2 interact with the lamina to facilitate both nuclear 
positioning and regulation of LADs. 
 
2.5: Materials and Methods 
 
2.5.1: Identification of Lamin Association 
Mouse embryonic fibroblasts (FB) were purchased from ATCC (CRL-2752) and 
cultured according to their establish protocols.   Rag2-/- proB cells were derived by 
isolating lineage depleted hematopoietic cells from the bone marrow of B6 (Cg)-
Rag2tm1.1Cgn/J (JAX catalog # 008449), which harbor a deletion of exon 3 in the 
coding region of the RAG2 gene. Isolation was followed by ex-vivo differentiation and 
expansion on OP9 stromal cells initially with SCF and IL-7, then IL-7 alone in OptiMEM 
media with 5% FBS. DamID was performed as described previously (Reddy et al., 2008, 
Zullo, 2 012). Briefly, self-inactivating retroviral constructs pSMGV Dam-V5 (Dam-Only) 
and pSMGV Dam-V5-LMNB1 (Dam-LMNB1) were used to generate retrovirus using the 
Platinum-E packaging cell line (Cell Biolabs RV-101). Supernatants containing viral 
particles were collected between 48-72 hours post-transfection of the DamID constructs 
and collection times were pooled. C57BL/6 mouse embryonic fibroblasts were incubated 
overnight with either Dam-Only or Dam-LMNB1 viral supernatant and 8μg polybrene. Ex-
vivo expanded Rag2-/- proB cells were spinfected by centrifuging in 24- or 48-well plates 
at 500g for 2 hours with viral supernatant plus 3ng/mL interleukin-7 (IL-7) and 4µg 
polybrene at room temperature. Following the spin, the cells were allowed to recover for 
one hour at in a tissue culture incubator (5% CO2, 37°C with humidity) before removing 
the viral supernatants and moving onto OP-9 stromal cells with normal growth medium 




(Vogel, 2007 and Zullo, 2012). Briefly, DNA was isolated from cells expressing Dam or 
Dam-LMNB1 using Qiagen DNA Mini Kit (51306), precipitated and resuspended to 
1µg/µL. 2ug of of this genomic DNA was digested overnight with the restriction enzyme 
DpnI (NEB R0176L), which cuts at methylated GAmeTC.  After digestion,  double 
stranded adapters comprising  annealed Oligonucleotide AdRt ( 5’ –CTA ATA CGA CTC 
ACT ATA GGG CAG CGT GGT CGC GGC CGA GGA-3’) and AdRb (5’-TCC TCG GCC 
G-3’) were ligated overnight with the digested DpnI fragments (Roche T4 Ligase 
799009) followed by DPNII digestion (NEB R0543S) for 1 hour.  This material was 
amplified in ligation mediated PCR using AdR_PCR primer (5’-
GGTCGCGGCCGAGGATC-3’), Advantage cDNA polymerase (Clontech, 639105). The 
resulting material was checked by agarose gel electrophoresis to ensure that specific 
amplification of methylated DNA fragments occurred and then column purified (Qiagen 
QIAquick PCR purification kit, 28104). This material was used either for quantitative 
PCR assays or subjected to array hybridization. For QPCR assays we used the following 
primer sets: specific to a region of the TCIS insert (TCIS_ChIP_F1: AGC TTG GCG TAA 
TCA TGG TC and ChIP_R5: ATT AGG CAC CCC AGG CTT TA), specific to an internal 
Igh LAD region (J558 1: AGT GCA GGG CTC ACA GAA AA and J558 12: CAG CTC 
CAT CCC ATG GTT AGA) or to a Lamina-negative region in a LAD (a.k.a. ‘Dip’) 
(chr10:105245772_141bp_F: AGG GAC AGC CGT GGA GGA GC, 
chr10:105245772_141bp_R: CCG CACC GTC CGG TTC TCA G) (Reddy, 2008). For 
identification of large genomic regions, Dam-only and Dam-LMNB1 samples were 
labeled with Cy3 and Cy5 using a random prime strategy, and DamID samples were 
hybridized to NimbleGen Economy Array mouse  whole genome tiling array 3 of 4 
(Nimblegen, C7276-00-01 MM8, part of chromosome 9 –part of chromosome 14) using 




intensity log2 ratios Dam-LMNB1 to Dam-only were obtained using DEVA 1.0.2 software. 
All experiments were performed two independent times. DamID array signal intensity 
data was lifted-over to mm9 using the Galaxy converter tool, and then data from 
replicate arrays were averaged together (Goecks 2010, Blankenberg 2010, and Giardine 
2005).  DamID data was quantile normalized and smoothed using the preprocessCore R 
package (Bolstad BM et al), and then segmented via a modified circular binary 
segmentation using the DNAcopy R package 
(http://www.bioconductor.org/packages/release/bioc/manuals/DNAcopy/man/DNAcopy.p
df), which is an algorithm for identifying copy number differences which “tests for 
change-points using a maximal t-statistic with a permutation reference distribution to 
obtain the corresponding P-value” (Venkatraman, 2007).   A sliding window approach 
with window size 2kb was used to combine neighboring segments, using in-house perl 
scripts. Code and accessory scripts are available upon request. Regions identified that 
were smaller than 25kb were trimmed from total LAD data.  
 
2.5.2: Analysis of LADs and Genomic Features 
YY1, CTCF and H3K27me3  ChIP data were tested for statistically significant 
overlap of LADs in fibroblasts using the GenometriCorr package (Favorov, 2012, 
Mendenhall, 2010; Peric-Hupkes, 2010; Vella, 2012, Simon, 2013). The GenometriCorr 
package applies multiple spatial tests of independence including an absolute distance 
test (i.e. if two elements such as LADs and YY1 sites are a fixed distance from each 
other), projection test (i.e. testing for significant overlap between these two positions 
assuming they represent single points points) and the Jaccard test (testing for 
correlation of these two positions assuming that they are not points, but instead occupy 
some interval of the genome). In addition to these statistical tests, the intensities of the 




border regions (+/-50,000kbp) to generate intensity profiles of the tested binding data for 
CTCF, YY1, H3K27me3 and LMNB1 using the Genomation R package (Akalin, 
https://github.com/al2na/genomation). 200 bins were generated over the entire border 
interval (+/-50,000kbp) and signal intensities of binding data within each bin were 
averaged and plotted. 
 
2.5.3: Motif Identification 
BAC derived fragments DNA tested for repositioning effects were analyzed for 
known and de novo motifs, carried out with MemeSuite and MotifSuite (Bailey, 2009; 
Claeys, 2012). Specifically, sequences from relocating fragments were analyzed using 
both MemeSuite (Meme, Multiple Em for Motif Elicitation) using default parameters. 
Identified motifs were compared to the expected frequency in chromosome 11 
background (since the tested fragments were from this chromosome), generated using 
the MotifSuite background generator tool CreateBackgroundModel. Enrichment of the 
targeting versus background and non-relocating fragments was determined by utilizing 
0.5 threshold parameter.  Only motifs that displayed a two-fold enrichment were 
considered for further evaluation. The identified motifs were then mapped to the 
fragments with the MAST program (Motif Alignment and Search Tool) in the MEME suite  
(TL Bailey et al., 1998). We then further confirmed the enrichment using randomly 
identified sequences in chromosome 11 away from LAD border regions and subjecting 
these to the same motif mapping via MAST. Only motifs identified as enriched over 
background on relocating fragments were further examined to identify proteins which 







2.5.4: Bacterial Artificial Chromosomes and fragments for positioning analysis 
All BACs were obtained from the BACPAC Resource Center at Children’s 
Hospital Oakland Research Institute (Oakland, CA). The listing of BACs with their NCBI 
clone-IDs and the genes they contain is provided in Figure S1B. DNA fragments for 
analysis by random integration and switching analysis were created by sheering BAC 
DNA with a p200 Tip 5-10 times. DNA was then run out on a 0.5% agarose gel and DNA 
over 25kb was isolated and cloned into a pcDNA3 vector. The pcDNA3 plasmids 
harboring BAC fragments were then isolated from these clones and screened for BAC 
DNA insert on an agarose gel. Clones containing fragments from 10-30kb were sent as 
glycerol stocks to SeqWright Genomic Services (GE Healthcare, Houston Texas) to 
sequence fragments of BACs from each end. Identified fragments were cloned between 
the inverted loxP sites of the switch vector, see below. 2.5kb fragments from the DNA 
fragments of Ikzf1 fragment F from the vLAD near the gene Ikzf1 were amplified from the 
fragments with the following primers: M24_D6_1_w, TGG GAT AGT TCA CAA GAA 
GCA C, M24_D6_1_C, GTT CAT GCC TAT GGC ACA GC, M24_D6_2_w, ACT TCA 
TGC TGG GAG ACA GG, M24_D6_2_c, CTC TGC CTG TCC TGA AGC TC, 
M24_D6_3_w, CCA GTG TGA TGG TGC ATA CC, M24_D6_3_c, GAG GGT GTG TGT 
GTG TTT GG, M24_D6_4_w, ATC AAC CAA GAG GCC ACA AC, M24_D6_4_c, AGA 
AGC CTC AGT CCA TCG AG, M24_D6_5_w, TTC CTG GTG CAT CTG TGA AG, 
M24_D6_5_c, CCT ACG GAG CCA TTT TTC TG, M24_D6_6_w, CAG AAA AAT GGC 
TCC GTA GG, M24_D6_6_c, ACA GGA GCT GGA GTG GTG AC, M24_D6_7_w, ACT 
TCA ACC CCC ACT TTT CC, M24_D6_7_c, AGG GAG GCC TTA GAG CTG AC, 
M24_D6_8_w, GCA GAG TGG AAG CAA GGA AG, M24_D6_8_c, ACC AGG GTG 
ACC TTG AAC TC, M24_D6_9_w, TAA GGT GGC TGG AGA GAT GG, M24_D6_9_c, 





2.5.5: Plasmids used for nuclear compartmentalization analysis 
The TCIS vector was constructed by flanking a hygromycin phosphotransferase-
thymidine kinase gene (HYTK) with inverted LoxP sites. Subsequently, a 256-repeast 
lacO array was integrated upstream of the LoxP site. DNA fragments (see Bacterial 
Artificial Chromosomes and fragments for positioning analysis), for recombination, were 
cloned into a “switch” vector, the original RMCE vector L1HYTK1L (Feng, 1999) was 
digested with BamHI to remove the CMV promoter and hygromycin/thymidine kinase 
cassette, the resulting fragment containing the inverted loxP sites was end polished 
(NEBNext End Repair Module, NEB E6050S). Into this we cloned a HincII/EcoIRCI 
fragment containing the multiple cloning site from pBlueScript (pBS KS+). Cre 
Recombinase was introduced by co-transfection with Plasmid 24593, AAV-pgk-cre from 
Addgene (GenbankID: AY056050). The EGFP-LacI retroviral vector was made by 
ligating a DraI fragment containing GFP-LacI from p3’ssEGFP-LacI into an HpaI site in 
pMSCV-puro (Clonetech). YY1-EGFP-LacI fusion proteins were generated by ligating 
YY1 (Origene plasmid, MC208051 mouse cDNA digested with SalI and PspXI) upstream 
and in frame with EGFP-LacI in a retroviral vector (p3’ssEGFP-LacI, digested with SalI 
and PspXI).  Zbtb7b-EGFP-LacI fusion protein was generated by ligating Zbtb7b 
(DNASU plasmid ZBTB7B, pANT7_cGST; clone ID FLH264179.01L), digested with AvrII 
and PspXI) upstream and in frame with EGFP-LacI in a retroviral vector (p3’ssEGFP-
LacI, digested with SalI and PspXI).   
 
2.5.6: Generation and Propagation of C57BL/6 fibroblast cell lines and clones 
NIH3T3 derived C57BL/6 murine FB (ATCC: CRL-2752) were transduced with 
the EGFP-LacI retroviral vector and selected with puromycin (1µg/ml) to generate a line 




C57BL/6 EGFP-LacI lines with linearized BACs and hygromycin selectable lacO arrays. 
TCIS cell lines were generated by transfecting C57BL/6 FB with a linearized TCIS 
construct described above. Cells were selected for hygromycin resistance (500 g/ml) 
and clones were isolated and expanded. Single integration clones were screened for by 
QPCR and transfection with EGFP-LacI retroviral vector to visualize the insert site. 
Clones 12 and Y had single integrations of the TCIS system at a chromosomal position 
away from the nuclear lamina, as determined by microscopy and either presence or lack 
of an overlap in LMNB1 and EGFP-LacI accumulation at the lacO insert site. 
Transfections for TCIS line establishment and random integrations were performed with 
Fugene 6 (Promega). Site specific recombination was obtained by co-transfection of 
TCIS clones with DNA fragments cloned into a switch vector and Cre recombinase. 
Switched cells were then seeded at low density, 10,000 cells per well of a 6 well tissue 
culture dish and treated with 1µM gancyclovir for 24 hours. TCIS cells require a short 
treatment with gancyclovir and to be treated at low confluence. Negative gancyclovir 
selection occurs when the non-switched thymidine kinase gene cassette expresses 
thymidine kinase, which in turn phosphorylates gancyclovir. Phosphorylated gancyclovir 
is toxic to the cells, but once released into the media and affect neighboring cells that 
have successful switched and should be resistant to gancyclovir. Cells resistant to 
gancyclovir (1 M) we re  the        
for specific recombination in TCIS clones were performed with the Amaxa 
electroporation system (Lonza Nucleofector 4), to ensure essentially 100% transfection 
efficiency. Mirus’ Ingenio Electroporation Products (Mirus Bio LLC, MIR 50111) were 
used in combination with the Amaxa nucleofector. All cell lines were maintained in 
DMEM high with 10% FBS (US Defined Fetal Bovine Serum SH30070.03, Hyclone) in 




Corning/CellGro) and IPTG (1mM) when EGFP-LacI was present. To enable binding of 
EGFP-LacI, IPTG was removed from the cultures and cells were analyzed after 24 to 36 
hours in fresh media. YY1 and Zbtb7b-EGFP-LacI harboring cones were created by 
transduction of TCIS clones Y and 12 with the retroviral vector and selection with 
puromycin (1μg/ml). 
 
2.5.7: shRNA knock downs and drug treatments 
shLMNA was produced in our laboratory. shRNA mediated ‘knock-downs’ were 
carried out by infecting fibroblast clones with freshly produced lentivirus for the specific 
shRNA. Lentivirus was produced by co-transfecting the desired knock down construct, 
Delta 8.9 and vsvg vector into HEK293 cells. Virus was added to fibroblast cells at 
approximately 30-40% confluence and removed after 12-14 hours. New media was 
added to cells and they were assayed 4 days after infection. shRNA constructs were 
obtained from Sigma Aldridge; shZbtb7b: clone NM_009565.4-2183s21c1, shYY1: clone 
NM_009537.2-918s1c, shCTCF: clone NM_007794.1-1030s1c1, shEZH2: clone 
NM_007971.2-421s21c1, shLmnA/C: clone NM_001002011.2-901s21c. , shSuv39H1: 
clone NM_011514.1-1874s1c1. Off-target  controls were shRNA directed against firefly 
luciferase (CGCTGAGTACTTCGAAATGTC, a gift from the laboratory of Dr. Dan Raben, 
Johns Hopkins University, School of Medicine, Department of Biological Chemistry). For 
G9a inhibition, MEFs and TCIS clone lines were treated with 5µM Bix01294 for 24, 48 or 
60 hours as, indicated. To reduce H3K27me3, MEFs and TCIS clones were treated with 







2.5.8: Immunofluorescence and 3D DNA-ImmunoFISH 
Cells were prepared for IF by platting on sterilized 25mm round coverslips 
(German borosilicate glass #1.5, 1217N82, Harvard apparatus) in 6 well tissue culture 
dishes. The nuclear lamina was visualized using an anti-LMNB antibody (sc-6217, Goat 
IgG, Santa Cruz). IF coupled with DNA in situ hybridization on preserved nuclei (3D-
DNA-ImmunoFISH) was performed as previously described (Reddy, 2008). DNA 
hybridization probes were generated by nick translation in the presence of digoxigenin or 
biotin-conjugated nucleotides (Dig Nick Translation Kit, 11745816910 and Biotin Nick 
Translation kit, 11745824910, Roche). After probe hybridization an anti-LMNB antibody 
was used to mark the nuclear lamina. Other antibodies used; Histone H3 (sc-10809, 
Rabbit IgG, Santa Cruz Biotechnology, 1:1000), GFP (sc-8334, Rabbit IgG,, Santa Cruz 
Biotechnology, 1:1000), H3K27me3 (39155, Rabbit IgG, Active motif, 1:1000), H3K9me2 
(ab1220, Mouse IgG, Abcam, 1:200), H3K9me3 (ab8898, Rabbit IgG, Abcam, 1:500), 
Zbtb7b (ab20985, Rabbit IgG, Abcam, 1:500), LMNA/C (sc-20681, Rabbit IgG, Santa 
Cruz Biotechnology, 1:500), LMNA (sc-6214, Goat IgG, Santa Cruz Biotechnology, 
1:500), LacI (05-503, Mouse IgG1, Upstate Biologicals, 1:500), YY1 (sc-7341, Mouse 
IgG1,  Santa Cruz Biotechnology, 1:500), CTCF (ab128873, Rabbit IgG, Abcam, 1:500 ), 
and β actin (A5441, Mouse IgG1, Sigma, 1:5,000).  
 
2.5.9: Chromatin immunoprecipitation and qPCR 
Chromatin immunoprecipitation was performed as previously described (Reddy 
et al., 2008). Briefly, cells were fixed in 0.5% formaldehyde for 15 minutes and then 
quenched with saturating amounts of glycine.  Fixed cells were lysed in cell lysis buffer 
containing protease inhibitors [10mM Tris-Cl (pH 8.1) ,10mM NaCl, 0.5% NP-40] for 10 




nuclei lysis buffer containing protease inhibitors [50mM Tris-Cl (pH 8.1), 10mM EDTA 
and 1%SDS] for at least 10 minutes to generate the chromatin fraction.  This chromatin 
was sonicated to an average length of 600 base pairs and immunoprecipitated with 2.5-
5ug of the histone modification specific or control antibody [Antibodies: H3K27me3 
(39155, Rabbit IgG , Active motif), H3K9me2 (ab1220, Mouse IgG, Abcam), H3K9me3 
(ab8898, Rabbit IgG, Abcam)]. qPCR was carried out using Igh primers specific for a 
region in the center of the locus (distal V gene region) as indicated in Figure S5 and 
described previously (J558 10, AGT GCA GGG CTC ACA GAA AA and J558 12, CAG 
CTC CAT CCC ATG GTT AGA) (Reddy, 2008). Primers to test the chromatin state of 
TCIS insertions were specific to a region of the TCIS insert (TCIS_ChIP_F1, AGC TTG 
GCG TAA TCA TGG TC and ChIP_R5, ATT AGG CAC CCC AGG CTT TA). Control 
primers were, Acta2 up, CAG AGG AAT GCA GTG GAA GAG AC and Acta2 down, 
TCG CTT CCC AAA CAA GGA GC.  
 
2.5.10: Image acquisition and preparation details 
All Imaging was done on Zeiss Axiovision inverted fluorescence microscope fitted 
with an Apotome and Zeiss AxioCam MRm camera. The objective lens used was a 
Zeiss 100X apochromat oil immersion with a N.A. of 1.5 (Immersol 518, 
4449600000000, Zeiss). All immunofluorescence was carried out at room temperature 
on #1.5 coverslips. 3DImmuno-DNA-FISH studies were either carried out on #1.5 
coverslips, or on slides and mounted with #1.5 coverslips. All IF and 3D DNA 
ImmunoFISH samples were mounted in either VECTASHIELD (H-1000, Vector 
laboratories) or Slow-Fade Gold (s36937, Life Sciences). Zeiss Axiovision software was 
used for image acquisition. Images were exported as tiffs to NIH Image J for further 
analyses. EGFP-LacI/ lacO foci were scored as either overlapping with lamin signal 




only brightness and contrast. When comparing expression levels, experiments were 
done in parallel and imaged at the same exposure times and adjusted in parallel to show 
differences in protein expression Each experiment was prepared in duplicate and scored 
as either ‘peripheral’ or ‘not peripheral’ by two different people, one of which was blind to 
the experimental conditions. The data analyzed by these two individuals was compared 
to ensure accurate measurements. Standard deviation (SD) was then calculated on the 
average scores from these two observers on two independent experiments for each 
experiment (n=2, SD refers to SD between experiments). Only data collected by one of 
the individuals was included for determination of p-values to avoid aberrantly inflating the 
observed ‘n’. p-values for each experiment and condition were calculated by first 
converting our scored data into either ‘peripheral’ (=1) or ‘not peripheral’ (=0). The 
distributions of this converted data from a control experiment were compared to the 
treated/experimental data using an unpaired t-test.   
 
2.5.11: On-line supplemental materials 
Scripts for determining LAD domains are provided. 
“harr_et_al_rscript_normalization_segmentation_1.txt” provides the commands to use in 
R to normalize and segment DamID data into LADs. 
“harr_et_al_segmentation_consolidate_chrnames_2.pl” and 
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Herein we describe a method to study the role of cis elements in directing 
nuclear compartmentalization. The Tagged Chromosomal Insert Site (TCIS) system 
enables the integration of any DNA fragment into a specific locus to test directed 
targeting. In addition, this system is designed to assay a targeting event through both 
cytological and molecular means. Additionally this system can be used to not only study 
the means of directed targeting to the nuclear periphery but to study the effect of change 
in environment and the consequences on chromatin state and associated proteins to any 
nuclear sub-compartment of interest. 
 
3.2: Introduction 
The genome appears to be organized on multiple levels such that the spatial 
location of genes can dictate their interactions with interact with regulatory DNA 
elements and proteins (Reddy et al., 2008, Zullo et al., 2012, Lin and Murre, 2013, Mao 
et al., 2011, Luperchio et al., 2014, Wong et al., 2014). The nuclear periphery is enriched 
in heterochromatin and various studies have demonstrated that some developmental 
and cell type specific genes dynamically interact with this compartment dependent on 
cell state and gene activity (Reddy et al., 2008, Finlan et al, 2008, Zullo et al., 2012, 
Kosak et al, 2002, Szczerbal et al., 2009, Williams et al., 2006, Kumaran and Spector, 
2008, Meister et al., 2010, Harr et al., 2015, Zullo et al., 2015). The nuclear periphery is 
the region of the nucleus that underlies the nuclear envelope. The nuclear envelope is 
comprise of the inner and outer nuclear membranes (IMN and ONM, respectively), a 
multitude of resident proteins and in mammalian cells the nuclear lamina, which is 
composed of the filamentous proteins, B-type and A-type lamins that create a meshwork 
between the INM and chromatin (Wilson and Berk, 2010). The nuclear lamina has a 




spherical shape. New evidence suggests that the nuclear lamina may play a role in 
maintaining lamina associated domains (LADs) at the nuclear periphery. These large 
regions of DNA are shown to interact with large regions of the genome (0.1-10 Mb; 
Guelen et al., 2008; Peric-Hupkes et al., 2010). Additionally, the associations of these 
regions of the genome with the nuclear periphery are correlated with the presence of 
specific histone modifications that silence the resident genes (Bian et al., 2013, Towbin 
et al., 2012, Reddy et al, 2008, Harr et al, 2015). Only recently is evidence emerging to 
help understand how these large regions interact and are maintained at the nuclear 
periphery and the role of the nuclear lamina, resident INM proteins, transcription factors 
and chromatin state in this process.  
In this chapter we will describe a new system, the Tagged Chromosomal 
Insertion site (TCIS). The TCIS system is comprised of a recombination cassette, to 
allow site specific Cre-mediated heterologous recombination, as well as lacO arrays and 
is integrated in a single copy in a single location in fibroblast cells [Figure 3.1 (Belmont et 
al., 1999 and Feng et al., 1999)]. Thus, TCIS enables integration of a single copy of any 
DNA fragment into the genome by directed recombination into the TCIS site and, 
importantly, aids for visual identification of the disposition of the integrated insert through 
lacO/EGFP-LacI binding. Any genomic element of interest can be specifically 
recombined into the TCIS system to assay for association with a specific nuclear 
compartment. Furthermore the lacO/LacI component can be utilized for directed 
recruitment of any protein of interest though discrete tethering to the lacO arrays though 
an X-LacI fusion protein.  This system has been used to identify specific DNA elements 
from variable LADs that are sufficient to target to the nuclear periphery and come in 
molecular contact with the nuclear lamina in mammalian cells (Harr et al., 2015). 













Figure 3.1: The TCIS System and a flow chart showing the main steps for creating TCIS 
cell clines and integrating a DNA region of interest. The TCIS system has been designed 
to allow for site specific integration of any DNA region of interest into the genome. This is 
accomplished by establishing the TCIS system in a cell line of choice (e.g. murine 
fibroblasts). A linearized version of the TCIS system is composed of two previously 
described technologies: the lacO/LacI system and recombination mediated cassette 
exchange (RMCE). This linearized system is integrated into the cell line. The system 
contains a thymidine kinase hygromycin gene and these integrations will lead to a cell 
line that is hygromycin resistant. Next, isolate individual clones and screen for cell lines 
that contain single integrations by qPCR and microscopy (visualizing an EGFP-LacI 
protein accumulation at the lacO arrays). These cell lines can now be used for either 
recruitment of specific proteins to the lacO array through X-EGFP-LacI fusion proteins or 
by inserting any DNA of interest into the RMCE region of the system. The binding of (X-) 
EGFP-LacI can be controlled by IPTG addition and removal. In the absence of IPTG,   
(X-)EGFP-LacI will bind the lacO arrays in the TCIS system. To assay sequence 








Figure 3.1: The TCIS System and a flow chart showing the main steps for creating TCIS 





genomic data, from ChIP, DAM-ID and other methods is becoming available to make 
correlations between these regions, the TCIS system gives us the ability to discretely 
test the hypothesized associated factors and to assay how chromatin and nuclear 
periphery associated regions are interacting and in what manner (Figure 3.2). This 
system allows us to ask questions about LAD organization and formation, in vivo- 




3.3.1: Design of the TCIS System 
 
3.3.1a: Design and preparation of the TCIS System construct 
The system was developed by utilizing two previously described technologies; 
recombination mediated cassette exchange (RMCE) and the lacO/LacI system. RMCE 
allows for the integration of any DNA sequence of interest and the lacO/LacI system aids 
in visualization of the insert locating with the in the genome and/or site specific tethering 
(Feng et al, 1999; Belmont et al, 1999). The RMCE section is composed of inverted 
LoxP sites such that a cassette must always be present. Additionally, the LoxP sites 
flank a hygromycin phosphotransferase-thymidine kinase gene (HYTK) for both negative 
and positive selection. Next a 256-repeat lacO array is integrated upstream of the LoxP 
site. This construct is linearized and transfected into mammalian cells to facilitate 
integration into the genome. One could also introduce this construct by directed targeting 
using CRISPER technology and directed recombination into a desired location in the 
genome. When cloning the TCIS system extra care is taken to ensure that the lacO 













Figure 3.2: TCIS System and recruitment. (A) The TCIS system has been used to 
investigate the mechanism behind reorganization of chromatin regions to the nuclear 
periphery. Analysis is done by live cell imaging, immunofluorescence (IF) and 3D 
immuno-FISH, each obtaining similar results. Determination of interaction with a sub-
compartment of interest (e.g. the nuclear periphery) is determined by overlap on IF 
signals (e.g. EGFP-LacI and anti-Lamin B1). (B) The TCIS system is used to study 
protein targeting reorganization of chromatin to a sub-compartment of interest (e.g. the 
nuclear periphery) by tethering a protein of interest to the lacO arrays through EGFP-
LacI (X-EGFP-LacI). Top, schematic of reversible IPTG binding, allowing LacI/lacO 
binding upon IPTG withdraw. Bottom, tethering of YY1-EGFP-LacI to the TCIS locus, 
yiels peripheral targeting of the integrated TCIS system. (C) The TCIS system contains a 
RMCE region that harbors a thymidine-kinase hygromycin gene. This allow for negative 
selection after recombination of any DNA of interest. Additionally, PCR can be used to 
verify the integration of your DNA of interest. Primers are created such that they flank 
the TCIS system and integrated DNA. A successful integration will yield a gancyclovir 













The following is a protocol to reduce the occurrence of recombination: 
1. Transform electro- or chemically competent Stbl3 (Invitrogen) bacterial strain, or 
similar, with the above TCIS construct. Stbl3 bacteria, a rag null bacterial line 
(Stbl3 Competent E. coli, C7373-03, life technologies, genotype: F-
mcrB mrrhsdS20(rB-,mB-) recA13 supE44 ara-14 galK2 lacY1 proA2 rpsL20(StrR)xyl-5 λ-
leumtl-1) can better amplify repetitive or unstable DNA elements (lacO array). 
2. Plate transformed bacterial into an LB agar plate containing the appropriate 
selection agent (e.g. Ampicillin). 
3. Grow at 30°C overnight (approx. 16 hours). Lowering the incubation temperature 
will help in reducing recombination events and loss of the full 256 repeat lacO 
array. 
4. Pick 24 to 48 colonies (divisible by the number of places in a table top centrifuge, 
for convenience) and grow in 3ml of LB medium, with the appropriate selection 
agent, overnight at 30°C. Choosing a lot of colonies will increase the chance of 
having non-recombined constructs. 
5. Prepare DNA from 2ml of the overnight cultures saving some of each on ice or at 
4°C for inoculating large cultures after screening. 
6. Digest the prepared DNA with the restriction enzyme PvuII, which will yield two 
bands, a 13.5kb TCIS fragment and the backbone of the full length construct 
(2.4kb). If recombination has occurred the TCIS fragment containing the lacO 
array will yield multiple bands.  
7. Choose 3-6 clones that appear to have not recombined (only two bands are 
present) to grow large scale cultures overnight. Inoculate 250ml of LB medium 
containing the selection agent (ampicillin) with the reserved cultures.  
8. Grow the large scare cultures overnight at 30°C. The next morning prepare DNA 




the constructs have not recombined. Freeze a small portion (2ml) at -80°C for 
future use.  
 
3.3.1b: Generation of stable mammalian TCIS clone lines 
 Generation of stable mammalian clone lines containing the TCIS system allows 
for the ability to interrogate nuclear organization and structure at discrete loci without 
effect of position effect or cell line differences. We have created TCIS clones in both 
murine fibroblast and pro-B cell lines. This system could be adapted to any stable tissue 
culture line of interest. Additionally the TCIS construct could be engineered to create a 
mouse line where it is present in every cell.  
1. Transfect the linearized TCIS construct (PvuII digest) into your cell line of choice. 
Transfection with a nonliopsomal transfection agent such as Fugene6 (Promega, 
E2691) works well.  
2. After 48 hours place the cells under Hygromycin B selection (500μg/ml). 
Concentration of hygromycin will vary depending on the cell type being used. 
500μg/ml was determined to work well for TCIS integration into murine fibroblasts. 
Grow adherent cells so that colonies form, once colonies are visible pick and seed 
each colony in individual wells of a 24 well plate. For suspension cells, allow the 
cells to grow under selection for one week and then plate single colonies in a 96 
well plate and wait for them to grow up. Continuously grow cultures under 
hygromycin selection.  
3. Verify integration of the TCIS construct by qPCR using specific primers to the 
system. To determine copy number, compare to a single copy gene.  
4. Freeze clone lines that are single copy. These are the parental cell lines. 
5. Clones are further selected due to the disposition of the TCIS insert to a nuclear 




a construct for EGFP-LacI in the cells (see section, 3.3.3a: Design of the EGFP-
LacI construct for TCIS visualization). EGFP-LacI will bind to the lacO array in the 
TCIS system in the absence of IPTG (Isopropyl β-D-1-thiogalactopyranoside), 
thus marking the location of the TCIS integration in the nucleus, visible by a GFP 
focus. Once the protein in expressed, in the absence of IPTG, EGFP-LacI will bind 
the lacO arrays rapidly (within 12-24 hours). When IPTG is present in the media 
(1mM) EGFP-LacI is inhibited from binding lacO and no focus is visible. By live 
cell imaging and Immunofluorescence, in the absence of IPTG, a locus should be 
visible at the TCIS insert site less than 30% of the time (see section, 3.3.4b. 
Detection of re-location via immunofluorescence, for IF protocol). For increased 
visibility of the foci, 3D-Immuno FISH can be carried out with a probe to the lacO 
array (see section 3.3.4c. Detection of re-location via 3D-ImmunoFISH for 
quantitative analysis of compartmental association, for FISH protocol). When 
comparing IF and 3D-ImmunoFISH studies, the disposition of the TCIS foci is the 
same for each clone time. When EGFP-LacI is present in the cell line, always 
grow in the presence of 1mM IPTG. Only withdraw IPTG when conducting an 
experiment. Cell lines containing EGFP-LacI and the integrated TCIS site should 
be frozen and stored in liquid nitrogen for future use.  
6. Select for stable TCIS containing cell lines that are single copy by qPCR and 
visualization by immunofluoresnce and EGFP-LacI binding. Additionally choose 
cell lines in which the integration site an away from the compartment you wish to 
test. When studying the nuclear periphery, choose clones in which the integration 
is centrally disposed in the nucleus (and not in contact with the nuclear periphery 
as marked by anti Lamin B1 staining). If investigating the role of another nuclear 
sub-compartment ensure your insert is not already in close spatial proximity when 




7. Thaw and maintain the parental cell lines of choice at 70-80% confluence. 
Maintain cell lines under appropriate selection at all times, Hygromycin (500μg/ml) 
and 1μg/ml puromycin and when EGFP-LacI is being expressed.  
 
These stable cell lines now contain a single integration of the TCIS system and 
EGPF-LacI. It is recommended to store both a parental cell line with and without the 
EGFP-LacI protein present. Some experiments may require the use of a different 
flourophore and/or different tethering protein (X-EGFP-LacI, see section. 2.3.3b: Design 
of Fusion Proteins utilizing EGFP-LacI). 
 
3.3.2: Site specific recombination into TCIS cone lines  
 
3.3.2a: Design and creation of DNA to recombine into the TCIS site 
Any segment of DNA of interest can be recombined into the stably integrated 
TCIS system in established TCIS clones. The DNA of interest is easily obtained by 
purchasing readily available Bacterial Artificial Chromosomes (BACs, BACPAC 
Children's Hospital Oakland Research Institute in Oakland, California, USA) to a region 
of interest or by amplification from gDNA by specific primers to the region of interest.  
DNA of interest is cloned into a “switch” vector in which the DNA is flanked by inverted 
loxP sites. This vector is created my restriction digest (BamHI) of the original RMCE 
vector L1HYTK1L (Feng, 1999) to remove the CMV promoter and hygromycin/thymidine 
kinase cassette. We then cloned into the resulting end polished BamHI, LoxP containing 
fragment, a HincII/EcoRI fragment containing the multiple cloning site from pBlueScript 
(pBS KS+). The multiple cloning site allows for easy integration of any DNA of interest 





3.3.2b: Recombination of DNA into the TCIS site 
 After creation of a “switch” vector containing your DNA of interest, co-transfection 
of the prepared “switch” vector and Cre- recombinase expression vector into the stable 
TCIS clone line, will lead to the DNA of interest becoming integrated into the TCIS site 
by site specific recombination. The following protocol is recommended for highly efficient 
transformation (90-100%) and successful integration of your DNA of interest.  
1. Defrost parental TCIS clone lines and grow to 70-80% confluence. Make sure to 
grow cells under Hygromycin selection (500μg/ml). 
2. Transiently transfect cells by electroporation with the Amaxa electroporation 
system (Lonza, Nucleofector 4) using Mirus’ Ingenio Electroporation Products 
(Mirus Bio LLC, MIR 50111 or Lonza electroporation products). To Harvest cells, 
remove media and wash once with PBS. Add 0.05% Trypsin/EDTA to remove 
adherent cells form the dish. Quench with an equal amount of media and count 
cells. Each electroporation reaction will be for 106 cells.  
3. Centrifuge cells at 90 g, room temperature (25°C) for 10 minutes to pellet cells. 
Re-suspend cell pellet in 110μl/ reaction of room temperature Mirus’ Ingenio 
electroporation solution.  
4. Add 110μl cells to a 1.5ml tube containing 1-5μg highly purified plasmid DNA (in 
maximum 5μl). For recombination use 1:1, 2.5μg Cre-recombinase (Plasmid 
24593, AAV-pgk-cre from Addgene, GenbankID: AY056050) and 2.5μg “switch” 
vector harboring DNA of interest. Transfer the cells and DNA mixture to a cuvette 
and ensure sample is at the bottom of the cuvette and no bubbles are present.  
5. Electroporate cells with appropriate Amaxa program (U-30 for Murine fibroblasts). 
Immediately transfer cells from the cuvette to a 1.5ml tube containing 500ul, 37°C 
RPMI media and incubate cells at 37°C for 15 minutes. The incubation in calcium 




survival of the cells. Process no more than 6 samples at a time, to avoid storing 
cells in electroporation solution for more than 15 minutes. 
6. Transfer cells to one well of a 6 well dish containing pre-warmed (37°C) growth 
media (DMEM high, 10% FBS, pen/strep and glutamine), and place in a 37°C/5% 
CO2 incubator. Do not disturb cells for 24 hours. IMPORTAINT: At this point, no 
longer maintain the cells with hygromycin selection. Upon successful 
recombination the hygromycin phosphotransferase-thymidine kinase gene is no 
longer present. We find that use of Amaxa transformation yield nearly 100% 
transient transfection efficiency with minimal cell death. Within 7 days of 
transfection all transient DNA in absent from the cells. This is integral to studying 
single TCIS specific DNA recombination; you want to ensure that DNA other than 
at the desired location is not present transiently or by random integration into the 
genome.  
7. After growing cells for 24-48 hours, seed at 10,000 cells per well of a 6 well dish 
and add gancyclovir (1μM) to DMEM high media (10%FBS, Pen/step and 
glutamine). Incubate at 37°C/5% CO2 incubator for 24 hours.  
8. Remove media after 24 hours and replace with DMEM high (10% FBS, pen/strep 
and glutamine). Culture cells to maintain 10-40% confluence for the first week, 
changing the media every 24 hours. Cells that have successfully recombined and 
taken up the DNA fragment of interest, will no longer contain the hygromycin 
phosphotransferase-thymidine kinase gene. In the presence of gancyclovir, these 
cells are not affected. If recombination was not successful and the hygromycin 
phosphotransferase-thymidine kinase gene is still present, the cells will 
phosphorylate gancyclovir by the expressed thymidine kinase. Phosphorylated 
gancyclovir is toxic to the cells and once released into the media will affect 




gancyclovir, so cells are maintained at a low confluence and the media is changed 
regularly until a stable line is produced.  
9. Cells resistant to gancyclovir (1µM) are then expanded for nuclear positioning 
analysis. These cell lines should be frozen and stored in liquid nitrogen for future 
use.  
 
3.3.3: LacI/lacO recruitment 
Controllable recruitment of EGFP-LacI to the lacO arrays of the TCIS system is used 
to visualize the stable integration site. Accumulation of EGFP-LacI (after IPTG 
withdrawal) at the 256 lacO array, leads to visualization of the TCIS system by way of a 
small foci, visible by live cell imaging, Immunofluorescence or FISH. Additionally a fusion 
protein can be designed such that a protein of interest is tethered to the lacO array 
through the LacI and is visible by the presence of EGFP. 
 
3.3.3a: Design of the EGFP-LacI construct for TCIS visualization 
The EGFP-LacI retroviral vector was made by ligating a DraI restriction digested 
fragment containing GFP-LacI from p3’ssEGFP-LacI into an HpaI site in pMSCV-puro 
(Clonetech). This vector is transiently transfected into a viral packaging line (PlatE, 
Platinum-E, retroviral packaging Cell line, Cell biolabs, Inc), 24 hours after transient 
transfection, media is replaced with DMEM high, 10% FBS, pen/step, L-glutamine.  
Media is collected and replaced at, 36, 48 and 60 hours after transfection. The EGFP-
LacI packaged retrovirus containing media can be snap frozen on liquid nitrogen and 
stored at -80°C for later use.  
Parental TCIS cell lines are infected with the EGFP-LacI virus for 24, in the 




replaced with DMEM high (10%FBS, pen/strep and glutamine) and 1μg/ml puromycin is 
added to the cells to select for presence of EGFP-LacI.  
 
3.3.3b: Design of Fusion Proteins utilizing EGFP-LacI  
The lacO array of the TCIS system can be used to discretely tether any protein of 
interest to a discrete mammalian locus. By creating a protein X-EGFP-LacI fusion 
protein, one can control the binding of protein X at the TCIS locus, in the absence of 
presence of IPTG. X-EGFP-LacI fusion proteins are generated by ligating the cDNA for a 
protein of interest (lacking a stop codon) upstream and in frame with EGFP-LacI in a 
retroviral vector (p3’ssEGFP-LacI). 
 
3.3.4: Assaying Recruitment/ re-organization  
After successful integration of a fragment of DNA of interest or expression of a 
fusion X-EGFP-LacI protein in a TCIS cell line one can start to assay targeting to a 
specific nuclear compartment. An example is to assay for the association of either the 
targeting fragment or tethered protein to the nuclear periphery. The nuclear periphery is 
regularly demarcated by the lamina network that underlies the inner nuclear membrane. 
Directed targeting can be assayed by both cytological and molecular means. 
 
3.3.4a: Targeting a DNA fragment or discreetly tethered protein to a nuclear 
compartment  
1. Getting cells ready 
A. Thaw cells and grow to 70-80% confluence. For investigation of targeting 
sequences thaw cell lines containing DNA of interest, a non-targeting fragment 
and the parental cell line all harboring EGFP-LacI. For X-EGFP-LacI fusion 




Grow cells in selection media for the insert (or lack of) and for the EGFP-LacI and 
all under 1mM IPTG. X-EGFP-LacI fusion harboring cultures should be kept under 
hygromycin (500μg/ml) selection at all times. Cell lines containing recombined 
DNA of interest are no longer resistant to hygromycin and should no longer be 
kept under selection. 
B. When cell reach 70-80% confluence, plate onto coverslips, slides or a 6 well dish 
depending on the experiment (see below). 
2. Re-organization 
A. Once the cultures on either coverslips/slide or coverslips reach 50% confluence, 
remove the media and replace with media plus 1mM IPTG or media alone. Do not 
include selection reagents at this time. For DNA targeting experiments you should 
have a control line of cells containing the parental TCIS insert, and those 
containing the DNA of interest (experimental line). All of these are minus IPTG. 
For tethering fusion proteins you should have two sets of the following; cells 
harboring EGFP-LacI, and X-GFP-LacI. One set contains IPTG and the other is 
absent of IPTG. The X-GFP-LacI cells minus IPTG are the experimental cell line.  
B. Grow the cells for 24-48 hours. 
C. Analyze the cells as outlined below. 
 
3.3.4b. Detection of re-location via immunofluorescence 
1. Getting cells ready 
Grow Adherent cells on coverslips and for suspension cells attach to coverslips 
by coating with poly-L-lysine. Never allow cells to dry out during the following 






A. Remove media from cells and add 4% formaldehyde in 1x PBS to cells for 10-15 
minutes. For murine fibroblasts we use 10 minutes. Times are empirically 
determined for each cell type.  
B. Rinse three times in 1x PBS (2-3 minutes each) 
3. Permeabilization 
A. Incubate coverslips in 0.5% Triton X-100 in 1x PBS for 10-20 minutes. 
B. Rinse three times in 1x PBS (5 minutes each). 
4. Blocking and primary antibody incubation 
A. Block slides in 4% BSA in 1x PBS for 1-2 hours at room temperature in a humid 
environment. A humid chamber can be created by soaking a paper towel in water 
and placing this in the covered container in which you are storing your coverslips. 
Place blocking solution on a piece of parafilm. Place coverslip, cells facing down, 
onto the bubble of blocking media. Use approximately 100μl for 25mm round 
coverslips and 50μl for 12mm coverslips.  
B. Dilute primary antibodies in blocking solution. The dilution used will depend on the 
antibody. Start with the recommended concentration for immunofluorescence. The 
recommended concentrations for western blot and ChIP are not necessarily ideal 
for IF. The first time an experiment is done, test several dilutions and use the 
concentration that yields the best signal to noise ratio.  
C. On a new piece of parafilm place the diluted antibodies and transfer the coverslips 
from the blocking solution onto the antibody solution (cells facing down, as above). 
If the coverslips are difficult to remove, take 100μl blocking solution and pipette 
under the edge of the coverslip, this will help loosen them up. Incubate in a humid 
chamber at room temperature for at least one hour, or overnight at 4°C. 
D. Wash coverslips three times in 1x PBS for 10 minutes each. Gently remove 




stringent wash can be done by adding 0.1% Triton- X 100 to the 1x PBS used for 
washing.  
5. Secondary Antibody detection and mounting 
A. Dilute secondary antibodies in the blocking solution. Incubate cells in antibodies 
as done above.  
B. Incubate in a humid chamber for 1-2 hours at room temperature. 
C. Gently return over slips to the culture dish (cells facing up) and wash three times 
in 1x PBS for 10 minutes each. 
D. If desired, stain cells in DAPI or Hoechst (1/10,000 dilution in 1x PBS, 10μg/ml 
stock solution) for 30 seconds to 1 minute. Rinse once with 1x PBS. We do not 
recommend using a mounting media containing DAPI. Our recommended short 
incubation time with Hoechst allows for visualization of fine details that can be 
swamped out with over staining.  
E. Prepare slides by adding 25ul VECTASHIELD (H-1000, Vector laboratories) or 
Slow-Fade Gold (s36937, Life Sciences) mounting media. Gently dry coverslip by 
taping the edge against a dry paper towel and invert the cover slip (cells down) 
onto the mounting media. Blot excess mounting media from the slide by very gently 
pressing with a paper towel. Seal the coverslip with nail polish.  
 
Allow slides to dry for a few hours to overnight before imaging. This incubation time will 
allow for the mounting media, which contains an anti-fade solution to fully penetrate the 







3.3.4c. Detection of re-location via 3D-ImmunoFISH for quantitative analysis of 
compartmental association. 
3D immuno-FISH allows for visualization of the TCIS insert site and endogenous 
proteins or by expression of X-EGFP-LacI. This allows for quantitative analysis of the 
TCIS disposition within the nucleus with respect to the compartment or protein of 
interest. In the absence of IPTG, the TCIS insert cannot be visualized by 
immunofluoresnce due to the lack of accumulation if (X-)EGFP-LacI at the TCIS insert 
site. To image these control cells, FISH must be done. The protocol presented here is an 
adaption from Solovei et al. (2002) and Reddy et al. (2008), see these protocols for more 
detailed information.  
1. 3D Immuno FISH Day 1: preparing slides and making probes 
A. Prepare cells. Plate cells onto UV sterilized slides in a larger dish. For adherent 
cells: puddle 250,000 cells in 250μl media (a 25mm diameter spot) onto slides and 
let sit for 5-10 minutes. Flood dish with media. Allows cells to fully adhere by 
incubating at 37°C/5% CO2 for a few hours to overnight. For suspension cells: 
Puddle 0.5-1 x 106 cells in a 25mm diameter spot on a  UV sterilized poly-L-lysine 
coated slide. Let cells sit for 5-10 minutes and flood dish with media.  
B. Fix cells. To ensure that fixation does not affect nuclear morphology, stain the 
cells on one slide with a viable nuclear stain like Hoechst, measure nuclear 
diameter and look at general morphology. Keep this in mind to ensure that nuclear 
volume and morphology is maintained after completing the FISH protocol.  
I. Fix cells in 4% paraformaldehyde in 1xPBS for 10-20 minutes. Fixative can be 
added directly to the tissue culture dish (into the media) or done in a coplin jar. 
Fibroblasts are fixed for 15 minutes.  




C. First Permeabilization: Make a fresh solution of 0.5% Triton X-100 and 0.5% 
Saponin in 1x PBS. Incubate slides for 10-20 minutes and then rinse three times 
for 5 minutes each in 1x PBS.   
D. HCL treatment: Make 0.1N HCl and 20% glycerol in 1x PBS (w/v). Incubate slides 
in 0.1N HCl for 10 minutes. Immediately flick excess HCl from slides and place 
into 20% glycerol solution. Incubate in glycerol/1xPBS for at least 1 hour. 
Continue with freeze thaw or store overnight at 4°C.  
E. Make FISH probes according to standard nick translation protocols. We use the 
direct labeling or dig- bio- labeling kits available from Roche (Catalog # 
11745816910 and 11745824910). To detect the TCIS insert site, label the plasmid 
DNA previously prepared. When making probe ensure that, the majority of the 
probe is between 200 and 700 bp in size.  
2. 3D Immuno FISH Day 2: Freeze thaws Permeabilization and probe hybridization 
A. Freeze/Thaw Permeabilization 
I. Continue from above, or remove slides from 4°C.  
II. Fill a Styrofoam container with Liquid nitrogen. Ensure there is enough liquid 
nitrogen to fully submerge a glass slide. With a large pair of forceps pick up 
one slide and submerge into the liquid nitrogen. Keep slide in liquid nitrogen 
until fully frozen. You will hear a “click” and/or bubbling will stop.  
III. Place the slide on a plastic grid to fully thaw.  
IV. Repeat for every slide. Repeat 4 times for each slide, re-submerging in 
glycerol every other freeze, to ensure that the slide does not dry out. 
V. Place slides at -80 degrees in a slide mailer if not using immediately. Slides 






B. Prepare probe 
I. Take 0.3ug of labeled DNA (from step 2.3.4c 1.E) and add Cot-1 (3ug/sample), 
Placental (6ug/sample), and sonicated salmon sperm (9ug/sample) DNA. 
These DNAs are the only blocking agents present during the hybridization 
procedure.  
II. Precipitate DNAs for 30 min to 1 hour at -80°C.  
III. Resuspend DNA in hybridization buffer (50% deionized formamide in 2xSSC 
with 10% dextran sulfate) by vortexing at 4°C for at least 1 hour.  
IV. Denature for 5 minutes at 80-94°C. 
V. Pre-anneal for 10 minutes- 2 hours at 37-42°C. 
C. RNase treatment 
I. Rinse slides in 1x PBS three times. 
  II. Prepare 50-100ug/ml RNase in 2x SSC. Place 200μl RNase solution on the 
slide and gently cover cells on the slide with a 24x 66mm glass coverslip. 
Incubate for 1 hour at room temperature in a humid chamber. 
  III. Rise slides in 2x SSC and leave in 2x SSC until hybridization. 
D. Denaturation/hybridization 
All hybridization steps should be carried out in a chemical hood while wearing 
appropriate personal protective equipment. Formamide is highly corrosive and acts as a 
teratogen. 
I. Warm up slide warmer to 37°C.  
II. Prepare 50ml deionized formamide in 2xSSC, pH 7.0 and 50ml formamide in 2x 
SSC, pH 7.0. If planning to hybridize more than 4 slides, prepare two batches of 




III. Place solutions in coplin jars and set water bath to 75-80°C. The temperature of 
the solution should be at 75°C- this will yield a hybridization temperature of 72°C 
when the temperature drops with addition of the slide.  
IV. When the solutions are 75°C, take one slide and place it into the 70% 
formamide solution for exactly three minutes. 
V. Immediately transfer the slide into the 50% formamide solution for exactly one 
minute. 
VI. Place 10μl hybridization cocktail, containing probe onto a 18x18mm coverslip 
on the slide warmer. 
VII. Remove the slide from 50% formamide solution and flick of excess liquid. 
Quickly place the slide (cell slide down) onto the coverslip. Flip-over and seal 
with rubber cement.  Allow rubber cement to set up on the slide warmer. 
VIII. Transfer the slides to humid chamber and incubate at 37°C overnight to 
several days.  
E. Detection of FISH probes and Immunofluorescence 
I. Remove rubber cement from slides and coverslips and place slides in 2x SSC. 
Dipping the slide and coverslip into 2xSSC will help in removing the slide.  
II. Wash slides three times in 50% formamide in 2x SSC at 42°C for seven minutes 
each. 
III. Wash slides three times, seven minutes each in 0.1-0.5 x SSC at 63°C. 
IV. Block cells in 4% BSA in 2xSSC for 30 minutes to 1 hour at room temperature 
in a humid chamber. Place block solution on the slide and hold in place using a 
coverslip. 
V. Add primary antibody at suggested concentration in blocking solution. Incubate 




VI. Wash slides three times in 2xSSC with 0.1% Triton X-100 at 37°C for 5 minutes 
each.  
VII. Add secondary antibodies for detection. For bio or dig labeled probe, a 
secondary for streptavidin or digoxigenin, respectively, and coupled to a 
flourophore is used. For any other antibodies used to mark specific nuclear 
proteins and or compartments, use a secondary antibody against the species of 
your primary antibody. Dilute antibodies at appropriate concentrations in blocking 
solution. Incubate for 1 hour at room temperature. 
VIII. Wash slides three times in 2xSSC with 0.1% Triton X-100 at 37°C for 5 minutes 
each and place in 2x SSC. 
IX. If desired, stain slides in Hoechst (1:10,000 dilution from a 10ug/ml stock 
solution) in 2x SSC, for 30 seconds to 1 minute. Place slides in 2x SSC until 
mounting.  
X. Mount slides by flicking the slide to remove as much excess 2xSSC as possible. 
Then add a small amount (100μl) of an anti-fade agent (Vectashield or Slowfade 
gold) drop wise to the slide. Cover with a large coverslip (#1.5) and gently blot to 
remove excess mounting agent. Use nail polish to seal the edges and hold the 
coverslip in place.  
XI. Store slides, flat and in the dark at 4°C until used for imaging.  
 
3.3.4d: Determination of Molecular contact-Dam-ID 
 TCIS system was designed to visually track the targeting of a single locus within 
the nucleus. The ability to visualize the TCIS system through the binding of EGFP-
LacI/lacO is easily assayed by microscopy but is limited by yielding only cytological data. 
The protocol DNA Adenine Methyltransferase Identification (or Dam-ID) has been 




proteins of interest (INM proteins, L2β exct.) This protocol was originally published by 
Griel et al. (2006) and adapted for mammalian cells as described in Vogel et al. (2006), 
Reddy et al. (2008) and Zullo et al. (2012). Herein we describe the protocol for marking 
interaction of DNA with the filamentous lamin proteins underlying the nuclear periphery.  
1. Creation of DamID Virus. DamID constructs should be stably expressed in your cell 
line of interest at a very low concentration. Self-inactivating retroviral constructs 
pSMGV Dam-V5 (Dam-Only) and pSMGV Dam-V5-LMNB1 (Dam-LMNB1) were used 
to generate retrovirus (see 3.3.3a: Design of the EGFP-LacI construct for TCIS 
visualization, for Virus production protocol). The Dam-Only construct is critical to 
determine base background levels of DNA adenine methyl transferase activity within 
the nucleus and is your control throughout the experiment.  
2. TCIS clone cells are defrosted and seeded to be at 40-50% confluence and were 
incubated overnight with either Dam-Only or Dam-LMNB1 viral supernatant and 8μg 
polybrene.  
3. Cells are grown for 48-60 hours while harboring the DamID constructs.  
4. Cells are then harvested for DNA isolation using Qiagen DNA Mini Kit (51306) and 
DNA is resuspend at 1μg/μL.  
5. 2μg of the genomic DNA for each condition is then digested overnight with the 
restriction enzyme DpnI (NEB R0176L), which cuts at methylated GAmeTC. This will 
cut at any site in which the Dam fusion protein has come in contact and marked 
GATC with a methylated adenine.    
6. After digestion,  double stranded adapters comprising  annealed Oligonucleotide AdRt 
( 5’ –CTA ATA CGA CTC ACT ATA GGG CAG CGT GGT CGC GGC CGA GGA-3’) 
and AdRb (5’-TCC TCG GCC G-3’) are ligated overnight with the digested DpnI 




7. The ligated material is then digested by DpnII (NEB R0543S) for 1 hour. This 
digestion step ensures that any non-methylated GATC regions are not included in the 
analysis.    
8. The resulting material is then amplified by ligation mediated PCR using AdR_PCR 
primer (5’-GGTCGCGGCCGAGGATC-3’) and Advantage cDNA polymerase 
(Clontech, 639105).  
9. The resulting amplified material is then checked to ensure that specific amplification of 
methylated DNA fragments occurred, by running a small sample on agarose gel 
electrophoresis. The amplified material should appear as a broad smear of equal 
intensity for all samples.  
10. Next, Column purify the remaining amplified material (Qiagen QIAquick PCR 
purification kit, 28104).  
 
The column purified material can now be used for quantitative PCR assays. For 
testing of molecular contact of either DNA targeted or X-EGFP-lacI fusion proteins 
directed nuclear peripheral association in TCIS fibroblast, we carry out qPCR analysis 
using a primer set specific for the TCIS insert (TCIS_ChIP_F1: AGC TTG GCG TAA 
TCA TGG TC and ChIP_R5: ATT AGG CAC CCC AGG CTT TA), specific to an internal 
Igh LAD region (J558 1: AGT GCA GGG CTC ACA GAA AA and J558 12: CAG CTC 
CAT CCC ATG GTT AGA) or to a Lamina-negative region in a LAD (a.k.a. ‘Dip’) 
(chr10:105245772_141bp_F: AGG GAC AGC CGT GGA GGA GC, 
chr10:105245772_141bp_R: CCG CACC GTC CGG TTC TCA G) (Reddy, 2008). The 
primers to an internal IgH Lamina associated regions are a positive control for lamina 





3.3.4e: Consequences of relocation: determination of histone modifications due to re-
organization-ChIP 
 While the TCIS system enables us to study directed targeting of a specific region 
of chromatin by cytological and molecular means, we can expand upon this study by 
examining the consequences of nuclear re-organization of a discrete locus. The TCIS 
locus can be targeted to any region of interest in the nucleus (e.g. the nuclear lamina) 
and then one can father investigate the changes in chromatin state before and after re-
location by Chromatin Immunoprecipitation (ChIP). The following ChIP protocol is 
adapted from Reddy at al. (2008). 
1. Prepare cells. Seed cells 1-2 days before fixation, so that the cells will be 70-80% 
confluent on the day of fixation. For each ChIP, process between 20-100 x106 cells, 
depending on downstream step requirements.  
2. Once cells reach confluence, fix in 0.5% formaldehyde for 15 minutes. Add 
formaldehyde directly to the tissue culture dish and rock gently.  
3. Immediately after fixation quench with saturating amounts of glycine (0.125mM).  
IMPORTAINT: For all following steps keep cells, and reagents on ice. Supplement all 
regents with fresh protease inhibitor.  
3. Rinse cells with cold 1xPBS.  
4. Add 10ml 1xPBS scrape cells from dish using a flat cell scrapper. Transfer cells to a 
chilled 50ml tube. 
5. Rinse dish one more time with 5 ml 1x PBS to collect remaining cells and transfer to 
50 ml tube. 
6. Once all cells have been collected, Centrifuge at 2,500g for 10 minutes to pellet the 
cells. 
7. Decant the supernatant and lyse cells in cell lysis buffer containing protease inhibitors 




8. Next pellet the nuclei by centrifugation, 10 min at 4°C.  
9. Decant the supernatant and resuspend nuclei in nuclei lysis buffer containing 
protease inhibitors [50mM Tris-Cl (pH 8.1), 10mM EDTA and 1% SDS] for at least 10 
minutes to release the chromatin.   
10. Sonicate chromatin to an average length of 600 base pairs, by probe sonication or 
with a Biorupter (Diagenode). We find that use of the Biorupter, gives optimal results. 
11. Dilute sonicated DNA to 1-5 106 cell/ml in IP dilution buffer (50mM Tris-HCL, pH 7.4, 
150mM NaCl, 1% (v/v) igepal, 1mM EDTA, pH 8 with protease inhibitors) and aliquot 
in 1.5ml tubes. These samples can be frozen on dry ice and stored at -80°C or used 
directly for immunoprecipitation. Note: store samples in 1mL aliquots and save a few 
vials at 5-20% this volume to use in a later step as your input sample.  
12. Add 2.5-5ug of the histone modification specific or control antibody (e.g. H3K27me3 
(39155, Rabbit IgG, Active motif), H3K9me2 (ab1220, Mouse IgG, Abcam), H3K9me3 
(ab8898, Rabbit IgG, Abcam)) to each 1.5 ml tube of chromatin. Incubate overnight at 
4°C. 
13. Add magnetic capture beads (e.g. Protein G magnetic dynabeads, Invitrogen 
100.04D) to the chromatin and antibody mix and incubate with constant rotation for 1-
2 hours at 4°C. Do not exceed 2 hours of incubation time. After the incubation, your 
chromatin is now bound to your anti-body of interest and in turn bound to the 
magnetic beads though Protein G. At this step include an input samples. This is used 
to determine percent of input during final qPCR analysis. Input can be 5-20% of your 
total chromatin sample. 
14. Pellet beads using magnetic capture and carefully remove the supernatant that 
contains the unbound antibody and chromatin fraction.  Wash the magnetic beads 
bound to the antibody/DNA complex for 5 minutes each with 1mL of the following 




EDTA, 20mM Tris-HCl, pH 8.1, 150mM NaCl), high salt wash buffer (1% Triton X-100, 
2mM EDTA, 20mM Tris-HCl, pH 8.1, 500mM NaCl ), LiCl wash buffer (0.25M LiCl, 
0.5% IGEPAL, 1mM EDTA, 10mM Tris, pH 8.1). Then wash once with 1x 10mM Tris, 
EDTA.  
IMPORTAINT: Be careful and consistent with pipetting during washes. To quantitate 
by qPCR after ChIP you do not assay for DNA concentration but test against input 
samples and compare relative amounts of your target region pulled down by the 
tested antibody all as compared to an IgG control.  
15. Elude DNA from beads by incubating in elution buffer (50mM NaHCO3, 1% (w/v) 
SDS), at room temperature with constant rotation for 30 minutes, followed by a 10 
minute incubation at 37°C. Save 10% of your elute sample or boil beads (after elution) 
with 2x SDS page loading buffer for western analysis.  
16. Reverse cross-link the eluted DNA/antibody complex by adding 10% of the volume, 
NaCl (5M), incubate overnight at 65°C.  
17. After reverse cross-link, RNAse treat samples and column purify DNA.  
 Next qPCR is carried out on your eluted DNA. For investigation of the chromatin 
state of the TCIS locus before and after lamina association we use primers to a specific 
region of the TCIS insert (TCIS_ChIP_F1, AGC TTG GCG TAA TCA TGG TC and 
ChIP_R5, ATT AGG CAC CCC AGG CTT TA). Primers should be designed as both 
positive and negative controls for each histone modification assayed.  
 
3.4: Concluding remarks 
Mounting evidence supports that the nucleus is organized into discrete 
compartments that regulate gene activity and function. In this chapter we describe a 
method to assay the directed re-organization of chromatin to any nuclear 




sequences from variable lamina associated domains that have the ability to target to the 
nuclear lamina in single copies. Furthermore directed tethering of a protein, YY1, 
identified in the process of re-organizing chromatin to the nuclear lamina can be 
visualized and quantitated by both cytological and molecular methods (Harr et al., 2015). 
Additionally this system has allowed us to examine the consequences of association of 
discrete loci with the nuclear lamina and periphery. Importantly this system can be 
expanded to examine any nuclear compartment of interest with the discovery of new 
targets and regions of interest, through either discovery of new targeting DNA cis 
elements and/or specific proteins that when tethers to the lacO arrays and lead to 














This dissertation presents a novel method for understanding the structural and 
functional relationship between epigenetic modifications and nuclear architecture. It has 
been observed that the dynamic organization of the nucleus contributes to regulation of 
gene expression in both normal cell state, and throughout development and loss of 
organization has been implicated in disease. How the overall three-dimensional structure 
of the nucleus plays a role in these processes is only beginning to become understood. 
With the advent of genome wide methods to profile the molecular interactions of nuclear 
sub-domains and protein interactions, there will be a lot of information from a variety of 
cell lines at different time points in development, that we must make sense of. What is 
important to note is that these genome wide studies are all done on a population basis 
and may not truly represent the exact state in a single cell. To understand how structural 
population studies apply to functionality in the cell and the mechanisms behind the 
process, we need to ask questions that directly probe chromatin state and effects on 
nuclear organization in a testable/controllable way. 
 Genome-wide LAD data from two different cell types has les up to identify vLAD 
regions that contain developmentally regulated genes. We hypothesize that these vLAD 
regions act as a level of regulation over the genes expression. We use the Tagged 
Chromosomal Insertion Site (TCIS) system to determine structure-function relationships 
of the vLAD DNA sequences. The TCIS system makes it possible to have site specific 
recombination of any DNA of interest at a specific locus in the murine genome. This 
allows for investigation of cis targeting elements without the pitfalls of random integration 
studies that are susceptible to positon effect and are done in multiple copies that can 
confound the results. Additionally we can recruit chromatin modifying and structural 
proteins of interest to the same site through lacO arrays. The TCIS system makes it 
possible to determine the mechanism behind the structural and functional relationships 




The role of the nuclear periphery as a regulatory compartment to control gene 
regulation is only truly starting to become understood. By integrating genome-wide data 
(Dam-ID) in multiple cell types, we have identified regions of the genome that are lamina 
associated and vary depending on cell type. We have discovered that genes that are 
critical for cell development are enriched within these variable lamina associated 
domains, when otherwise lamina proximal regions have been considered gene poor. 
This suggests that the nuclear periphery acts as an integral compartment in the nucleus 
that not only harbor repressed gene poor regions of the genome, but also acts as a 
critical level of regulation over genetic loci that are import for cell type specificity and 
development.  Here in this work, we have discovered that DNA elements within LADs 
and components of the PRC2 complex establish de novo lamina associations.  In 
addition, we suggest a role for levels of A-type lamins and, specifically, lamin C in 
regulating this repositioning which appears to be reliant of the chromatin modifications 
H3K27me3 and H3K9me2/3. In chapter 2 of this thesis, we used our TCIS system to 
identify sequences from fibroblast specific variable LADs containing the Ikzf1 and Bcl11a 
loci. This work focused on LAD border regions due to the over representation in 
developmentally regulated genes. We show that these regions are sufficient for 
relocalization of an ectopic site to the nuclear lamina that re-organization is dependent 
on the PRC2 component YY1 and H3K27me3, a histone modification dependent on 
PRC2 and demonstrated to be enriched in these regions at endogenous LADs. In 
addition, we demonstrate, in agreement with two previous reports, that association with 
the nuclear lamina is also dependent on H3K9me2/3 (Bian et al., 2013; Towbin et al., 
2012).  This approach enabled the discovery of both cell-type specific (e.g. BTB/POZ 
domain proteins) and more ubiquitous components (CTCF and YY1) involved in 
scaffolding and maintaining segments of vLADs at the nuclear periphery. Recent reports 




organizing and regulating chromatin at the nuclear periphery (Reddy et al., 2008, 
Zuleger et al., 2013; and reviewed in Wong et al., 2014). We therefore propose a model 
for regulation of vLADs that incorporates cell type specific transcription factors along with 
chromatin modifiers and organizers to facilitate cell-type specific genome organization. 
It will be of special interest to determine the underlying molecular machinery in 
establishment of broader lamina associated domains as well as the functional 
consequences of repositioning of a genic region to the nuclear lamina. Identification of 
specific factors that lead to LAD formation and delimiting of LAD boundaries will be of 
great import in understanding how organization at the lamina is influences development 
and how its dysregulation leads to disease. Additionally, our TCIS technology can be 
utilized to better understand the structure/functional relationships of not only the nuclear 
lamins as a functional sub-compartment but any nuclear compartment of interest. This 
technology will allow us to study in vivo, the epigenetic and macromolecular composition 









Molecular interactions of proteins at the nuclear periphery, 





When studying interactions of chromatin with the nuclear lamina we primarily 
relay on either cytological data or population based molecular assays (DNA 
methyltransferase identification, Dam-ID, through the utilization of a Lamin B1-Dam 
fusion protein). We were interested in methods that would detect molecular contact in 
single cells, such that they were more than just cytological and correlative. Most of the 
cytological data is scored by observing an overlap in flourophore signal, such as EGFP-
LacI foci over lapping with an anti-lamin B1 stain, to denote the nuclear periphery. An 
overlap in these signals would be considered peripherally associated. DamID was also 
used in some cases to confirm molecular contact, though on a population basis. 
Bimolecular fluorescence complementation (BiFC) analysis allows for us to assay 
molecular contact of two nuclear regions in vivo and on a single cell basis (Figure AI.1). 
This technique was developed by Tom Kerppola as a means to study protein 
interactions in living cells (Kerppola, 2010; Hu et al., 2008).  The assay is based upon 
the association of two non-florescent portions of a fluorescent protein, that when are 
brought in close, molecular proximity of each other by way of an interaction between 
proteins that are fused to each fragment, reconstitute fluorescence. This technology is 
beneficial in the study of any protein-protein interactions due to the ability to visualize 
these interactions inside a living cell. One can further identify differences among the 
population that would be drowned out in population based studies, and identify 
localization to sub-structures that otherwise would not be possible. Also, by assaying the 
interactions in living cells, one can avoid cell lysis and the possibility of missing the 
contents of the cell, which may lead to changes in protein interactions.  One thing to note 
is that these experiments are done with exogenously expressed proteins and once the 












Figure AI.1: Bimolecular fluorescence complementation (BiFC). Schematic of the BiFC 
assay. Two non-fluorescent parts (YN and YC) of yellow fluorescent protein (YFP) are 
expressed as a fusion protein with possible interaction partners (Blue and Red shapes). 
Molecular association of the interaction partners leads to the formation of a full YFP that 







required to form the active flourophore this assay is not a representation of what is 
happening in real-time. That being said, BiFC still is a powerful tool of visualization of 
protein-protein complex interactions with in live cells.  
We utilized the BiFC approach to show molecular contact of a reorganized region 
of chromatin that has targeted to the nuclear periphery. Our utilization of the TCIS 
system for both random integration and discrete loci targeting studies made this possible 
through the lacO/LacI component of the system. TCIS is built upon two previously 
described technologies, Recombination Mediated Cassette Exchange (RMCE) and 
lacO/LacI (Feng et al., 1999; Belmont et al., 1999). The RMCE region makes it possible 
to directly integrate any DNA segment of interest into the TCIS system while the 
lacO/LacI system makes it possible to visualize the position of the locus in mammalian 
nuclei by the binding and accumulation of EGFP-LacI, to 256 lacO arrays. We designed 
a wide combination of the BiFC constructs by creating fusion proteins of each YFP non- 
fluorescent fragments, VN or YC to LacI at both the C and N terminus. Additionally, we 
created a variety of fusion proteins between inner nuclear membrane proteins and each 
YFP non-fluorescent fragments. We used LaminB1 and Lap2β initially. LaminB1 is a 
filamentous protein found underlying the inner nuclear membrane that gives structure 
and righty to the nucleus as well as has been shown to interact with IMN proteins, 
chromatin and various transcription factors with in mammalian cells. Lap2β is an INM, 
resident protein that has been implicated in interacting with repressed chromatin at the 
nuclear periphery (Zullo et al., 2012). The co-expression of a LacI- or INM- (LaminB1 or 
Lap2β) YFP fragments fusion proteins that would complement each other within our 
TCIS clone lines, would lead to the accumulation of LacI-VN/YC at the lacO arrays (in 
the absence of IPTG), while the LMN-YN/YC fusion protein would be expressed and 




the Lap2β and Lamina fusions the BiFC fragment is inserted at the N-terminus of the 
proteins because in Lap2β the N-terminus is nucleoplasmic, while the C-terminus is not 
and for Lamins, the C-terminus cannot be blocked due to a farnesylation of a C-terminal 
CAAX box. In the presence of a fragments that has been integrated into the TCIS 
system and targets to the nuclear periphery we would expect that LacI-VN/YC would 
bind the lacO arrays, and after reorganization of the TCIS locus to the nuclear periphery, 
the close molecular proximity of the LacI-VN/Y and IMN-YN/YC proteins would lead to 
the formation of a functional fluorescent YFP proteins and thus visualization of the 
molecular interaction. We first validated these studies by visualizing the interactions of 
IMN proteins with themselves (known interactions) and recruitment of lacO to the 
nuclear periphery though random integration of peripheral targeting fragments and lacO 
array. Random integration of these fragments lead to high copy numbers of lacO arrays 
and the targeting fragments which are easier to visualize than the single TCIS locus 
alone, and these were done as first pass experiments.  
Expression of BiFC constructs of LaminB1 and Lap2β show inner nuclear 
membrane proteins interactions (Figure AI.2). Co-expression of YN-LaminB1 and YC-
LaminB1 and YN-Lap2β plus YC-Lap2β, show a faint but distinct rim staining and co-
localizes with anti-LaminB1 staining. It is important to note is that these images were 
taken only 7 hours after transfection of the constructs into murine fibroblast cells. A 
further study of various time points after transfection, shows that overexpression of the 
exogenous proteins leads to perturbation of nuclear morphology, as seen by LaminB1 
staining, the BiFC signal and overall DAPI staining (Figure AI.2). Initial studies 











Figure AI.2: Expression of BiFC Lamin B1 and Lap2b fusion proteins show inner nuclear 
membrane (INM) protein interactions. Immunofluorescence was done in Bl63T3 
fibroblasts expressing YN- or YC- INM proteins, Lamin B1 (LmnB) or Lap2 (L2B). 





factors, bZIP and Jun a Rel family protein (Hu et al., 2002). These studies allowed for 
visualization of the BiFC complex 18-48 hours after transfection. Early time points were 
avoided due to the lack of fluorescence seen with initial BiFC complex formation. We 
note that when studying proteins such as Lamin B1 and Lap2β within 14 hours there is a 
perturbation of nuclear architecture and therefore these results would be cofounded by 
perturbed conditions within the cell (Figure AI.3). These results none-the-less, confirm 
that our fusion construct produce a stable IMN proteins that will target to its resident sun-
nuclear compartment, and self-interact as expected, to form a fluorescent YFP protein, 
thus showing functionality of the BiFC system.  
To query the molecular contact of chromatin regions targeting to the nuclear 
periphery we utilized the lacO/LacI system and co-integration of lacO and fragmented 
Bacterial Artificial Chromosome (BAC) DNA identified to be in lamina associated 
domains (LADs) in murine fibroblasts. This DNA, which is found within LADs in 
fibroblasts, when randomly integrated into the genome of murine fibroblast, targets to the 
nuclear periphery, as done in previous studies (Zullo et al, 2012; Harr et al, 2015). In this 
case we co-express either YN/YC-LaminB1- or YN/YC-Lap2β with VN/YC-LacI in 
fibroblast cells harboring random integrations of BAC and lacO DNA. In the absence of 
IPTG the VN/YC-LacI fusion protein will bind the lacO arrays at the random integration 
site, and if these DNA fragments have targeted to the nuclear periphery we expect to 
see the formation of a fluorescent BiFC complex, as the lacO/LacI complex comes in 
close proximity to the nuclear periphery (Figure AI.4). As a verification of visualization, a 
positive control showing the interaction of VN-LacI and YC-LacI shows the random 
integration of the lacO and BAC DNA (Figure AI.4, panel A). Molecular contact of the 







Figure AI.3: Expression of co-transfected YN-Lamin B1 and YC-Lamin B1 proteins 
leads to perturbation of nuclear morphology if expressed at higher levels and for too 
long. BiFC constructs for YN-LmnB1 and YC-LmnB1 are co-transfected into Bl6/3t3 
Fibroblast cells. Cells are fixed at 7, 14 and 48 hours after transfection and stained for 







Figure AI.4: Co-expression of BiFC constructs show peripheral positioning and 
molecular contact (through BiFC) of LADed regions with the lamina and inner nuclear 
membrane proteins. A region of the Ikaros LAD encompassing BAC RP23-349M24 was 
randomly sheared and co-integrated with a lacO array in Bl6/3T3 fibroblasts. Panel A 
shows complementation of YN-LacI and YC-LacI at the integration site. Panels B-E 
show complementation of YN or YC-LacI with YN or YC-LaminB1 or Lap2b. Leftmost 
column shows both Lamin B1 staining (red) and complementation of BiFC fusion 
proteins (green). The second column depicts the fluorescence signal alone from the 
complementing proteins. The third and fourth columns are staining for LacI (cyan) and 





different configurations of the fusions proteins. A variety of DNA from fibroblast specific 
DNA was tested for its ability to target to the nuclear periphery, as well as a negative 
control of integration of lacO arrays alone (Figure AI.5).  
The BiFC technique worked well to confirm the intra-molecular interaction of IMN 
proteins, LaminB1 and Lap2β with themselves, as well as show, in vivo, the molecular 
contact of a region of chromatin targeting to and residing at the nuclear periphery. This 
technique will prove difficult to carry out in single integration clones of the TCIS system, 
due to the faint levels of YFP expression upon complex of BiFC over background, at 





Figure AII.5: Random integration of LacO arrays and sheared BACs from Ikaros, Bcl11a 
and IgH Lamin Associated Domains into Bl6/3T3 fibroblasts direct peripheral association 
from ectopic sites in the genome. The left column shows eGFP-LacI (green) 
accumulation at lacO arrays. The right column shows Bi-Molecular Fluorescence 
Complementation of VN-LacI and YC-LacI accumulating at lacO arrays. Lamin B1 












Every cell has the same genetic information (DNA), yet each cell, depending on 
its time or point in development will vary in phenotype and ability to interact with its 
extracellular environment. Each cell determines that part of its genome to appropriately 
express due to regulatory information within its epigenome. The epigenome includes 
chemical modifications to DNA (in the form of methylation) or post translational 
modifications (PTMs) to histones.  With an advancing understanding of the influence of 
epigenetic factors and the proteins that play a role in controlling them, the underlying 
molecular mechanisms for this level of genetic control are poorly understood.  
Chromatin Affinity Purification with Mass Spectrometry (ChAP-MS) is being 
combined with the TCIS System to investigate the role of factors that play a role in 
control over a single genetic locus. ChAP-MS was developed and first utilized in S. 
cerevisiae where Byrum et al. specifically enriched for a ~1,000 base-pair section 
of GAL1 chromatin under transcriptionally active and repressive conditions. After 
enriching for a small region of DNA in two different states they further identified the 
specifically bound proteins and histone posttranslational modifications (Byrum at al. 
2012). This technique yields much more information than traditional chromatin 
immunoprecipitation (ChIP), due to its ability to query the nuclear environment without 
bias. ChIP is limited in its ability to assay for the proteome and histone modifications due 
to the lack of specific antibodies, as well as relying on their use (a biased probe). 
Additionally, it can lead to the identification of combinatorial histone modifications on a 
single histone as obtained from a native environment, something that was not able to be 
done before. ChAP-MS allows for the isolation of a native genomic locus that is then 
assayed by high resolution proteomic identification by mass spectroscopy, to identify 
without bias, any interacting proteins and posttranslational modifications.   
 To assay these questions in mammalian cells we need to be able to integrate the 




murine fibroblast cells and has been used to study the role of reorganization of 
chromatin to the nuclear periphery (Harr et al., 2015). These established cell lines are 
being used to integrate ChAP-MS constructs at a single mammalian locus. By Cre- 
recombinase mediated recombination, the TCIS site can accept a DNA construct 
containing the components required for ChAP-MS. With the inclusion of a test gene 
(GFP) driven by an inducible promoter we can assay the effect of gene modulation on 
macromolecular chromatin composition in vivo, in mammalian cells (Figure AII.1 A/B). 
Additionally, through the lacO arrays of the TCIS system, we can also recruit chromatin 
modifiers to assay the effects on macromolecular chromatin composition (Figure AII.1 
C). Furthermore we can elaborate on previous work carried out in TCIS. TCIS system 
has recently been utilized to recruit a discrete genomic region to the nuclear periphery 
through either the integration of a targeting cis element, or targeting of a specific protein 
(YY1). By introducing the ChAP-MS construct into existing TCIS cell lines that have 
previously been queried for their ability to re-organize chromatin; we can further refine 
and understand the protein players and changes in chromatin composition 
(modifications) with recruitment to the nuclear periphery (Figure AII.1 D). One can image 
this could be adapted to determine macromolecular chromatin composition and 
consequences of targeting to any compartment with in the nucleus with the discovery of 











Figure AI.1: Integration of ChAP-MS in mammalian cells via TCIS technology and 
schematics for proposed experiments. (A) A ChAP-MS construct containing a LexA or 
TALEN protein binding domain, and an enhancer/promoter region driving a destabilized 
GFP reporter gene. This construct is cloned inside inverted LoxP sites in a “switch” 
vector. Expression of this vector in the presence of Cre recombinase in a cell line 
containing the TCIS integration will lead to recombination mediated cassette exchange 
and insertion of the ChAP-MS construct at a single integration site. The ChAP-ME 
technology once integrated into mammalian cells can be used in multiple ways to assay 
macromolecular protein composition at a single locus in vivo. In each of these scenarios, 
material will be processed by ChIP and subsequent Mass-Spectroscopy analysis. (B) 
Investigation of the macromolecular protein composition before and after gene induction 
by an inducible promoter. (C) Investigation of the macromolecular protein composition 
before and after recruitment of histone modifying proteins (HMP) to the locus through 
either the LexA/TALEN binding sites or lacO arrays. (D) Investigation of the 
macromolecular protein composition before and after reorganization of a discrete locus. 
This can be done through the use of either a targeting DNA element or recruitment of a 
protein to the either the LexA/TALEN binding sites or lacO arrays, that would lead to an 






Figure AII.1: Integration of ChAP-MS in mammalian cells via TCIS technology and 








This project will start with the development of constructs (Figure AII.2 A) followed 
by validation by testing the ability to pull down a locus with the LexA-PrA handles. Next 
we will establishment of a method for growing large enough cultures for ChAP-MS: To 
carry out ChIP on a single locus in a mammalian cell, cells will be needed in the range 
107-1010 cells/condition. The Chap-MS construct will then be incorporated into murine 
mammalian cells though site directed recombination into established TCIS Clone lines Y 
and 12. After manipulation of experimental conditions (hypoxia/ heat shock/ nuclear 
compartmentalization or recruitment of HMP) cells will go through an established ChIP 
protocol (Byrum et al., 2010) followed by Identification of macromolecular protein 
complexes and PTMs by mass spectroscopy.  
 
Creation of the ChAP-MS-TCIS constructs and establishment in mammalian cells: 
The LexA binding site was engineered immediately upstream of an inducible 
enhancer/promotor (hypoxia inducible element OR heat shock element) flowed by a 
minimal promoter, to drive the expression of a destabilized GFP. The LexA DNA binding 
site will interact with a constitutively expressed LexA-Protein A (LexA-PrA) fusion 
protein, that can be used as a protein “handle” to affinity purify our chromatin region of 
interest. The destabilized GFP contains a PEST domain that targets it to the proteasome 
for rapid degradation, allowing for real time analysis of the expression of a test gene at 
our locus, by flow cytometry or microscopy (Salama et al., 1994; Belizario et al., 2008). 





Figure AII.2: Adaptation of ChAP-MS to inducible mammalian promoters. (A) Schematic 
of the TCIS System and; integration of cloned test region having an inducible promoters 
which containing 6 or 12 binding sites for either LexA or TAL, and which binding sites  
directing expression of a destabilized dsRED gene. Hsp70: heat shock protein 70, HBR-
6U: 6 hypoxia- inducible repeats from the HIF1α promoter. (B) Left, schematic showing 
recruitment of YY1 to a distinct locus. Right, ChIP-QPCR qPCR of locus after pull-down 
with α-H3K9me2, α-H3K9me3, or α-H3K27me3, as indicated showing YY1-induced 





conditions) or inactive gene. This engineered region will be incorporated into a ‘switch’ 
cassette vector, which contains the inverted LoxP (L1) elements. These L1 elements will 
flank the engineered region, allowing for incorporation of the inducible E/P-LexA-DsGFP 
into the TCIS system (Figure AII.A). 
To recruit histone modifying proteins (HMPs) to our locus, fusion proteins will be 
created with a protein of interest and either LexA/TALENs of LacI. The inclusion of a 
GFP in the fusion will allow for the ability to visualize the accumulation of protein X-
EGFP-LacI (LexA) at the TCIS locus and in live cells, visualize any nuclear 
compartmentalization or movements that may take place. We will test HMPs that have 
the potential to alter the epigenome. For active genes (under induced conditions) we will 
recruit HMPs that can lead to repression, such as; G9a, Suv39H2, PRDM, HDAC1 and 
HDAC3. To inactive genes (permissive conditions) we will recruit HATs and HMPs that 
are known to lead to gene activation such as; p300, MLL3/4 and UTX). It is expected 
that by recruitment leading to a change in gene expression we will be able to alter the 
chromatin state of the TCIS locus as assayed by real-time PCR and ChIP.  
 
Downstream analysis: 
After setting up the TCIS-ChAP-MS system in mammalian cells, experimental 
cells will be fixated and chromatin affinity purification will be carried out with conditions 
already optimized for yeast (Byrum et al., 2012). LexA-PrA enrichment of the E/P 
elements will initially be determined by ChIP followed by quantitative PCR using primers 
to the engineered promoter regions.  We will explore enrichment of 1kb sections as well 
as larger fragments. Proteins co-enriching with LexA-PrA will then be determined by I-
DIRT (Smart et al., 2009; Byrum et al., 2012). I-DIRT (Isotopic differentiation of 
interactions as random or targeted), is a technique the makes it possible to differentiate 




(Tackett et al., 2005). A major hurdle with using mass-spectroscopy to identify proteins 
with in complexes isolated from mammalian systems is the presence of nonspecific 
proteins. This technique uses isotopic labeling to label specific proteins interactors and 
at the analysis step, determine which proteins are contaminants and not part of the 
complex due to differential isotopic labeling. In our system we expect enrichment of the 




This project will shed light on to the mechanisms behind epigenetic regulation at 
a specific locus in mammalian cells. It will lead to the identification of proteins involved in 
this process as well as give an unbiased view of the chromatin state before and after 
locus manipulation by either gene induction, histone modification (though directed 
targeting of histone modifying proteins) and change in nuclear environment my directed 
targeting of the locus to a nuclear  sub-compartment (e.g. the nuclear periphery).   This 
work leads to the generation of new methodologies to manipulate and study the 













Our studies of identifying cis and trans factors involved in reorganization of 
chromatin to the nuclear periphery revealed a role for YY1, chromatin modifications, 
H3K27me3, H3K9me2/3 and architectural a proteins including CTCF, and Lamin A/C 
(Harr et al., 2015). We hypothesize that lamin A/C may be helping anchor or maintain 
chromatin at the periphery once it has reached this nuclear sub-compartment.  An earlier 
study (in collaboration with our lab) had implicated Lap2β, an inner nuclear membrane 
(INM) protein as being involved in this process, though we were unable to verify this in 
our system (Zullo et al, 2008). We choose to investigate the role of the lamins in this 
process due to their prominent location at the nuclear periphery. Lamins are 
intermediate filament proteins that assemble as a fibrous structure up against the inner 
nuclear membrane. In this position they play a role of providing nuclear structure and 
have been shown to interact with chromatin. The Lamina network includes two major 
classes, the A-type and B-type lamins (Gerace and Berk, 1988; Stuurman et al., 1998; 
Moir et al., 1994). B-type lamins include lamin B1 and lamin B2, each of which are 
produced from different genes (Höger et al., 1990; Weber et al. 1990). On the other 
hand, the two major isoforms of A-type lamins in mammals are lamins A and C, which 
are generated from the game gene, LMNA (Fisher et al., 1986; McKeon et al., 1986).  
Lamin A and Lamin C are the same for the first 566 amino acids, yet differ at the 
C-terminal domain. Lamin A is 72 kDa and is produced by an alternate 5’ splice site with 
in exon 10 that includes two more exons than lamin C. Lamin C is 65 kDa, and it is 
produced from a transcript composed of exons 1-10. This results a unique C terminus for 
each lamina A and C, lamin A having 98 unique amino acids and lamin C had 6 unique 
amino acids in this region (Al-Saaidi and Bross, 2014). This variation on the amino acid 
sequences leads to lamin C being left as it is, while lamin A is further processed such 




translational modification that produced mature lamin A. This multi-part process involves 
the farnesylation of cysteine (by farnesyltransferase) followed by the removal of the last 
three amino acids by ZMPSTE5, and lastly carboxy-methylation of the C-terminal 
farnesylcysteine by isoprenylcysteine carboxyl methyltransferase Some evidence is 
emerging showing that these proteins play distinct biological roles (see review; Al-Saaidi 
and Bross, 2014; Zwerger and Medalia, 2013).     
The nuclear periphery is being highly studied for its roles in gene regulation and 
a better understanding as to why specific regions of the genome reside within it, as a 
sub-compartment. Cytological and genome-wide studies have shown that the nuclear 
periphery contains large lamins associated domains (LADs) of chromatin that are either 
gene poor, or that have an over representation of developmentally regulated genes that 
when in this compartment are repressed. The lamins are believed to play an important 
role in development and disease due to the occurrence of a variety of developmental 
disorders that arise from mutations in the proteins of the nuclear lamina (Nagano and 
Arahata, 2000; Worman, 2012). We are investigating the role of A-type lamins in either 
helping with recruitment or maintenance de novo LAD formation. At this time of the study 
we had available to us knockdowns for the LMNA gene that lead to reduction in both 
lamin A and lamin C proteins (Harr et al., 2015). Specific roles for lamin A and C have 
not been highly vetted due to the lack of tools to study their differences in mammalian 
cells. In the Reddy lab, Xianrong Wong created highly specific shRNA targets that result 
in the reduction of either lamin A or lamin C. This gives us the unique opportunity to 
investigate is these isoforms played a different role in maintenance of de novo LADs at 
the nuclear periphery.  
Recent studies have implicated lamin A in large scale chromatin organization, but 
they were not able to differentiate between the role of lamin A and C (McCord et al., 




involved genome organization, suggesting that lamin C is playing a role due to the clear 
results we obtained showing that lamin A is not necessary for recruitment of retention of 
chromatin at the nuclear periphery. This suggests, contrary to the commonly held 
position that there is functional redundancy between lamina A and lamin C, that lamin C 
may be specifically involved in instructing peripheral positioning. Consistent with this, are 
studies that “lamin C-only” mice (missing lamin A but with normal lamin C levels) are 
viable, yet LMNA/C+/- have perturbed differentiation (Fong et al., 2006; Sehgal et al., 
2013). 
In further support of lamin C playing a distinct role in organization of chromatin at 
the nuclear periphery we utilized a lamin C specific knockdown construct to investigate 
how lamin C plays a role in establishment and maintenance of peripheral associating 
chromatin. Reduction in lamin C levels in TCIS fibroblast clones harboring either a 
peripherally targeting DNA fragment or YY1-EGFP-LacI proteins that targets to the 
nuclear periphery, we see that there is a loss of association and maintenance of TCIS de 
novo LADs. This is in contrast to lamin A specific knockdowns, that to not perturb the 
peripheral association of these lamina associating regions (Figure AIII.1). Additionally, 
endogenous loci present in variable lamina associated regions containing the 
developmentally regulated genes; Igh, Ikaros and bcl11a,  and that have all been shown 
to have differential lamina association dependent on their transcriptional status in the 













Figure AIII.1: Lamin C and not Lamin A is involved in de novo LAD organization and/or 
maintenance. Left, Representative immunofluorescence images of fibroblast TCIS clone 
Y. TCIS clone Y harboring a peripheral targeting fragment (I) from the fibroblast vLAD 
containing Ikzf1, was treated with shRNA for luciferase (off-target control), Lamin A or 
Lamin C (two different shRNA targets). Pop out is 300X. Green= EGFP-LacI at lacO 
array, red= anti-LaminB1. Array indicates TCIS locus. Right, Quantitation of 









Figure AIII.2: Knockdown of Lamin A/C and not Lamin A alone reduces peripheral 
association of Ikzf1 and IgH endogenous loci in mouse embryonic fibroblasts. 
Representative images of fluorescence in situ hybridization with a DNA probe to either 
the Ikzf1 or IgH locus in mouse embryonic fibroblast cells (Cyan and yellow, 
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• Worked directly with teachers to develop and improve their abilities in teaching 
science. 
 
• Worked with students to plan and carry out a yearlong science project.  
 
Supplemental Instructor       Aug/2003-Dec/2003 
General Sciences Tutor                  Aug/2002-May/2003 
Tutorial Center: Sonoma State University. Rohnert Park, CA   
                                                                      The SSU tutorial center provides free 
tutoring to students. The tutorial center employs senior students as supplemental 
instructors to lower level undergraduates.  
• Created lesson plans for a group of 20-50 general chemistry students to help 
increase their study skills and assist them in succeeding in the course.  
 
• Worked with the general chemistry course coordinator to plan out supplemental 
lesson plans. 
 
• Assisted in writing and proctoring examinations. 
 








Laboratory Technician                                                                      Jan/2005-May/2005 
Medlogics Device Corporation, Santa Rosa, CA        
 
Medlogics is a small biotech with a fully operational R&D laboratory, with the goal of 
developing drug releasing medical devices.  
 
• Assisted in preparing the new clean analytical chemistry laboratory for GLP 
compliance.  
 





American Society for Cell Biology 
Rho-Chi Pharmacy Honor Society 
Tri-Beta Biological Honor Society 




AWARDS, HONORS AND SCHOLORSHIPS 
 
• Scholarship to attend CSHL Nuclear Organization and Function 2014 Meeting 
• Towson University/JHU PDO Teaching Fellow, 2014 
• Life time member of Rho-Chi Pharmaceutical Honor Society, 2007-present 
• Recipient of full scholarship to attend the Cold Spring Harbor Course:  
Molecular and Cellular Biology of Xenopus, April 2007 
• First place in the MicroMed Laboratories research project, 2005 
• Recipient of Tri-Beta Biological Honor Society research grant, 2004 
• Life time member of Tri-Beta Biological Honor Society, 2001-Present  
• Recipient of Sonoma State University Dean's List/Honors, 2001-2005 
• Recipient of the National Merit Scholarship, 2001-2005 
• Recipient of the Golden State Scholar Share-governor's scholarship program, 
2001 
• Awarded the Sonoma State University President Scholarship, 2001 
• Awarded the Loys T. Newton Scholarship, Scottish Rite, 2001 










Invited / in preparation 
Harr, J.C., Wong X., Reddy K.L. (invited, 2015) “Targeting chromatin to the nuclear 
lamina.” Nucleus.  
Harr, J.C. and Reddy, K.L. (invited, 2015) “A new perspective on the nuclear periphery.” 
BioEssays  
Harr, J.C. and Reddy K.L. (invited, Jan 2016 issue) Tagged Chromosomal Insertion Site 
(TCIS): A system for live cell imaging and tracking of a single element without 
position effect. Methods in Enzymology  
Published 
Harr, J.C., Luperchio, T.R., Wong X., Cohen, E., Wheelan, S., Reddy, K. (2015) 
Directed targeting of chromatin to the nuclear lamina is mediated by chromatin state 
and A-type lamins”. The Journal of Cell Biology 208(1) 33-52. 
*This work is highlighted in a biobytes podcast, a Johns Hopkins SOM press 
release and in a Research Highlight (Nature Reviews Molecular Cell Biology 16, 
68 (2015) doi:10.1038/nrm3948) 
 
Harr J.C., and Reddy K.L. (2013) Live Cell Imaging of Nuclear Dynamics. In: Lennarz 
W.J. and Lane M.D. (eds.) The Encyclopedia of Biological Chemistry, vol. 2, pp. 
749-755. Waltham, MA: Academic Press. 
Zhu, J.-H., Chen, C.-L., Flavahan, S., Harr, J., Su, B., & Flavahan, N. A. (2011) Cyclic 
stretch stimulates vascular smooth muscle cell alignment by redox-dependent 
activation of Notch3. American journal of physiology Heart and circulatory 
physiology, 300(5), H1770–H1780.  
Harr J, Coyne L, Chandry A, Halliwell RF. (2008) An Electrophysiological Study of the 
Impact of Environmental Enrichment on Xenopus Laevis Oocytes. Animal Welfare 
Institute Quarterly, vol. 57(3)  
Harr J. (2007) An Electrophysiological Study of the Effects of Resveratrol and Catechin 
at GABAa Receptors. Thesis [M.S.] University of the Pacific 
 
ABSTRACTS/PRESENTATIONS 
Harr J.C., Reddy, K. Directed reorganization of chromatin to the nuclear lamina is 
mediated by chromatin state, YY1 and A-type lamins. Talk, ASCB, December 2014 
Wong, X. Harr, J.C., Reddy, K.R. The Role of A Type Lamins in Genome Organization. 




Harr, J.C., Luperchio, T.R., Wong X., Cohen, E., Wheelan, S., Reddy, K. Directed 
reorganization of chromatin to the nuclear lamina is mediated by YY1. Abs, CSHL 
Nuclear Organization and Function, August 2014 
Harr J, Zhu J-H, Chen, C-L, Flavahan NA, Su, BY. Redox regulation of tissue 
transglutaminase contributes to mechanosensitivity of vascular smooth muscle cells. 
ACCM Research Day, Abs. 2008 
Harr J, Payne T, Basi R, Blankenship J, Jones P. TEAM Science; Teaching, 
Experimenting and  Mentoring in Science. ACS, Abs. 2006 
Harr J, Martineau N, Works C. Photochemical Studies of a Model Compound for Iron-
only- Hydrogenase. ACS, Abs. 2005  
 
